Newly described cytosolic pattern recognition receptors mediate inflammatory glial responses to neurotropic viruses by Furr, Samantha  Rosa Lee & NC DOCKS at The University of North Carolina at Charlotte
 
 
NEWLY DESCRIBED CYTOSOLIC PATTERN RECOGNITION RECEPTORS 
MEDIATE INFLAMMATORY GLIAL RESPONSES TO NEUROTROPIC VIRUSES 
 
 
 
by 
 
Samantha Rosa Lee Furr 
 
 
 
 
A dissertation submitted to the faculty of 
The University of North Carolina at Charlotte 
in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in 
Biology 
 
Charlotte 
 
2012 
 
 
 
 
 
 
 
 
 
Approved by: 
 
______________________________
Dr. Ian Marriott 
 
______________________________ 
Dr. Kenneth L. Bost 
 
______________________________ 
Dr. Valery Z. Grdzelishvili 
 
______________________________ 
Dr. Julie M. Goodliffe 
 
______________________________ 
Dr. Andrew Harver
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2012 
Samantha Rosa Lee Furr 
ALL RIGHTS RESERVED 
 
 
 
 
 
 
iii 
 
ABSTRACT 
 
 
SAMANTHA ROSA LEE FURR.  Newly described cytosolic pattern recognition 
receptors mediate inflammatory glial responses to neurotropic viruses. (Under the 
direction of DR. IAN MARRIOTT) 
 
 
The rapid onset of potentially lethal neuroinflammation is a defining feature of 
viral encephalitis.  Glial cells are ideally positioned to respond to invading pathogens of 
the central nervous system (CNS) and produce key inflammatory mediators following 
viral infection.  However, the mechanisms by which resident CNS cells perceive such 
challenges have not been defined.  Recently, several cytosolic pattern recognition 
receptors, including retinoic acid-inducible gene I (RIG-I) and DNA-dependent activator 
of IFN regulatory factors (DAI), have been described that appear to function as 
intracellular sensors of RNA and DNA viruses, respectively.   Interestingly, recent 
studies suggest that RIG-I may also be able to recognize DNA pathogens in a polymerase 
III-dependent manner.  However, little is known regarding the expression of these novel 
intracellular viral sensors or their role in the CNS.  In the present study, we demonstrate 
that microglia and astrocytes constitutively express detectable levels of both RIG-I and 
DAI and their downstream adaptor molecules.  In addition, we show that expression of 
RIG-I and DAI by glial cells is elevated following infection with the model neurotropic 
RNA virus, vesicular stomatitis virus (VSV), and/or DNA viruses including the 
neurotropic virus herpes simplex virus-1 (HSV-1), or specific synthetic ligands for these 
viral sensors.  Importantly, these specific ligands elicit inflammatory mediator production 
by both microglia and astrocytes, and targeted knockdown of RIG-I or DAI attenuates 
such responses following RNA or DNA virus exposure, respectively, and limits the 
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production of soluble neurotoxic mediators by virally challenged cells.  Interestingly, 
glial inflammatory responses to the DNA virus HSV-1 were also dependent on the 
expression of RIG-I and the activity of polymerase III, while glial responses to the RNA 
virus VSV required the expression of RIG-I but were DAI and polymerase III 
independent.  These studies demonstrate that RIG-I and DAI play a critical role in the 
recognition of viral pathogens by resident CNS cells and suggest that these novel 
intracellular pattern recognition receptors may underlie the damaging inflammation and 
neuronal cell death associated with acute neurotropic viral infections.
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CHAPTER ONE:  INTRODUCTION 
 
 
Microbial and viral infections of the brain and spinal cord result in inflammation 
that underlies wide ranging symptoms including fever, headache, confusion, and in 
extreme cases, stroke, seizure, or even death.  The resulting disease is classified based on 
the area of the central nervous system (CNS) affected and can include the membranes 
that surround the brain (meningitis), spinal cord (myelitis), or inflammation within the 
brain parenchyma (encephalitis).  Of these, encephalitis tends to be associated with more 
significant alterations in the level of consciousness, cognitive defects, seizures, and focal 
neurological deficits than meningitis, although it should be noted that clinical 
presentation of these conditions often overlap.  The incidence of encephalitis in the 
United States has been estimated at approximately 20,000 new cases annually according 
to the Centers for Disease Control, and an average incidence of 1.9 cases per 100,000 
inhabitants has been reported in France for non-HIV patients (Stahl et al., 2008).  While 
encephalitis and meningitis can be caused by bacterial or fungal pathogens, viruses are 
the major causative agents of CNS infection worldwide, with a review of worldwide 
prospective studies yielding a minimum incidence of 10.5 per 100,000 acute encephalitis 
cases in children and 2.2 per 100,000 in adults, with an overall incidence of 6.34 per 
100,000 for all ages (Fidan et al., 2008).  However, it must be noted that these numbers 
are likely to be underestimations given the problems associated with diagnosis, 
particularly in developing countries (Sejvar, 2006).  
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Viral CNS infections can be very difficult to treat due to the rapid onset of severe 
disease symptoms that can occur even in otherwise healthy individuals.  Such infections 
trigger broad activation of glial cells including microglia and astrocytes, and the 
concomitant release of an array of proinflammatory molecules that can elicit both innate 
and adaptive immune responses.  While host responses limit viral replication and 
dissemination and can lead to infection resolution, overzealous or sustained inflammation 
within the CNS can result in significant neurological damage. 
One of the major challenges in the study and treatment of viral CNS infections is 
the wide range of etiological agents (Tunkel et al., 2008).  Both RNA and DNA viruses 
can infect the CNS and cause meningitis or encephalitis (as reviewed in Table 1), 
although an etiological diagnosis is established in less than 30% of cases (Stahl et al., 
2008).  While historically important RNA viruses that can cause encephalitis such as 
measles, mumps, and rubella have seen steep decreases in incidence as a result of 
immunization (Koskiniemi et al., 1997), rabies virus (RABV) remains an endemic cause 
of viral encephalitis in the United States and a serious public health concern.  RABV is 
transmitted from animals to humans and although rare, CNS infection results in 
uncontrolled virus replication, a prominent pro-inflammatory response, and death 
(Theerasurakarn et al., 1998).  Encephalitis due to this zoonotic virus is 100% fatal once 
neurological symptoms develop and accounts for several thousand deaths per year in 
Asian countries.  Interestingly, new RABV variants that can cause lethal encephalitis 
have recently been reported in the United States (as reviewed in Cliquet et al., 2004) and 
some evidence suggests that the incidence of RABV disease may be increasing due to the 
changing epidemiology of infection in animal populations (Whitley et al., 1999). 
 3 
TABLE 1:  Both RNA and DNA viruses are causative agents of encephalitis. 
     * Following development of neurological symptoms 
In addition, emerging RNA viral pathogens such as West Nile virus (WNV) 
(Gubler, 2008), Japanese encephalitis virus (JE), Australian bat Lyssavirus (Samaratunga 
et al., 1998), retroviruses, and Nipah virus (McCormack et al., 2002) have become 
increasingly important causes of encephalitis.  Nipah virus was first identified in 1999 
and the mortality rate associated with acute encephalitis caused by this virus has been 
estimated to be between 40% and 75%, with a 2001 outbreak resulting in a 63% mortality 
rate (as reviewed in Tyler, 2009).  While most survivors make a full recovery, 20% 
Virus Type Mortality 
rate 
Incidence Major molecules 
released 
WNV RNA 3-15% No reliable estimates TNF- , IL-1 , IFN 
RABV RNA > 99%* 55,000/yr TNF- , IL-1 , IL-6 
IFNs 
JE RNA 25-50% 30-50,000/yr 
- Local incidence rates 
1-10/100,000 
persons; 
- Can reach more than 
100/100,000 persons 
during outbreaks. 
- Travel-associated 
risk: 1/5,000–20,000 
per week of travel 
IL-1 , IL-8, IL-6 
TNF-  IFNs 
HSV-1 DNA 30-70% - Western country 
populations: 
0.2/100,000 persons 
- Neonatal HSV 
infection:  
2-3/10,000 live births 
TNF- , IL-1 , IL-6 
VZV DNA 25-100% 1/2000 infected 
persons 
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demonstrate neurological sequelae including persistent convulsions and personality 
changes, and a small number subsequently relapse or develop delayed-onset encephalitis.  
Worldwide, the flavivirus JE virus is the most common cause of arthropod-borne 
encephalitis with over 50,000 cases reported per year in China, Southeast Asia, and India 
(Whitley et al., 1999).  Epidemics due to this arbovirus result in a mortality rate that 
ranges from 30-50% with death usually occurring within the first week (Roos et al., 1999; 
Soloman et al., 2003), and the development of sustained neurological deficits in 
approximately half of the survivors (Ghosh et al., 2009).  Another flavivirus, WNV, is 
also transmitted by Culex spp. mosquitoes and can cause fatal encephalitis or long-term 
neurological sequelae.  Once inside the CNS, JE and WNV infect neurons (Koh et al., 
2005; Shrestha et al., 2003; Wang et al., 1997) leading to neuronal apoptosis (Liao et al., 
1998; Parquet et al., 2001) and causing severe immunopathology (Licon Luna et al., 
2002).  WNV has been associated with over 12,000 cases of encephalitis and/or 
meningitis in the US with a mortality rate of 9.5% as reported by the CDC, and is 
especially life-threatening in susceptible individuals such as the elderly (Debiasi and 
Tyler, 2006). 
DNA viral agents that can infect the CNS include varicella zoster virus (VZV) 
and several viruses in the human herpesvirus family that can cause encephalitis, including 
human herpesvirus 6 (Isaacson et al., 2005), herpes simplex virus 1 (HSV-1), and herpes 
simplex virus 2 (HSV-2) (Baringer., 2008).  VZV is a medically important cause of 
encephalitis, particularly in children younger than 16 years of age (Stahl et al., 2008), 
characterized by up to 25% mortality and rates close to 100% in immunocompromised 
patients.  However, HSV is considered to be an endemic cause of encephalitis in the 
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United States.  HSV-1 is the most frequent cause of this disease in adults (Stahl et al, 
2008) while HSV-2 is the most significant etiological agent of severe encephalitis in 
children accounting for approximately 10% of all cases in the U.S. (Bingham, 2000; Roos, 
1999).  Neonatal HSV-2 encephalitis, with treatment, has a mortality of 14% (compared 
to 85% without treatment) and severe neurological dysfunction is observed in 50 to 70% 
of surviving individuals.  HSV-1 encephalitis in older children represents the most 
common cause of sporadic fatal viral encephalitis (Baringer, 2008).  Untreated patients 
with HSV-1 encephalitis have a 70% mortality rate, while patients who receive early 
treatment have a 40% chance of recovering with no significant neurological deficits.  
However, despite appropriate diagnosis and therapy, the mortality rate remains at 30% 
(Baringer, 2008; Xu et al., 2006).  HSV encephalitis may follow primary infection but 
most cases are the due to the reactivation of latent virus in the olfactory bulb or 
trigeminal ganglia and subsequent retrograde axonal transport into the CNS (as reviewed 
in Conrady et al., 2010). 
 The complexity seen in viral encephalitis due to the array of causative agents, 
clinical presentations, and severity has made defining the mechanisms that underlie 
disease pathology challenging.  Ideally, host responses following CNS infection should 
result in rapid neutralization of the invading pathogen with minimal collateral damage to 
the sensitive and poorly regenerating neural tissue.  However, viral CNS infections are 
often associated with inadequate antiviral responses and/or the rapid and severe onset of 
damaging inflammation (as reviewed in Savarin and Bergmann, 2008).  While the brain 
has traditionally been viewed as a “victim organ” of infiltrating leukocytes, it has become 
increasingly apparent that specialized resident glial cells, such as microglia and astrocytes, 
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play an essential role in regulating the permeability of the blood-brain barrier, promoting 
the recruitment of leukocytes, and the activation of such cells following infiltration. 
1.1 Glial cells play a critical role in the initiation of virally-induced  
neuroinflammation  
 
Microglia and astrocytes are well known to play an important role in homeostasis 
within the CNS and to support neuronal cell function.  However, these cell types are 
increasingly recognized as key players in the development of protective immune 
responses or the progression of damaging inflammation during CNS disease states (Bauer 
et al., 1995; Stoll et al., 1999; Fischer et al., 2001; Dong and Benveniste, 2001).  
Microglia are resident myeloid immune cells of the CNS and, similar to other myeloid 
cells such as macrophages and dendritic cells, these cells are facultative phagocytes and 
express antigen presenting MHC class II molecules (Hickey and Kimpura., 1988).  
Importantly, microglia produce key pro-inflammatory mediators such as interleukin (IL)-
1  (Martin et al, 1993), tumor necrosis factor (TNF)-  (Streit et al., 1998), IL-6 (Kiefer 
et al., 1993), and bioactive IL-12 p70 (Suzumura et al., 1998; Aloisi et al., 1997) 
following activation.  Astrocytes are the major glial cell type in the brain and may also 
function as an immune effector cell (Dong and Benveniste, 2001).  Stimulated astrocytes 
can express an array of inflammatory cytokines and chemokines that can initiate 
leukocyte migration across the blood-brain barrier and promote effector functions in 
these infiltrating cells (Dong and Benveniste, 2001).  As such, these cells are ideally 
situated to detect and respond to invading pathogens such as neurotropic viruses. 
Viral infections in the CNS are known to broadly trigger glial activation and the 
release of pro-inflammatory molecules.  For example, it is known that pro-inflammatory 
cytokines, IFN-γ and TNF-α, are markedly increased in CNS tissues during HIV-1 
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infection in the brain and microglia have been shown to respond to HSV-1 by secreting 
pro-inflammatory and chemotactic molecules including TNF- , IL-1β, IL-6, IL-12, 
CCL7, CCL8, CCL9, CXCL1, CXCL2, CXCL4, and CXCL5 (Aravalli et al., 2005; 
Lokensgard et al., 2001).   Human microglia have also been shown to respond to RNA 
viruses including WNV by producing cytokines and chemokines (Cheeran et al., 2005).  
Elevated levels of IL-1β are readily detectable in neural tissue from WNV encephalitis 
patients and cultured human glia produce this potent inflammatory cytokine in response 
to WNV challenge (van Marle et al., 2007).  We have also documented the ability of 
primary cultured microglia and astrocytes to respond to several RNA and DNA viruses, 
including vesicular stomatitis virus (VSV), Sendai virus, and murine gammaherpesvirus 
(MHV)-68, by producing inflammatory mediators such as IL-6, TNF- , and IL-1  
(Chauhan et al., 2010; Rasley et al., 2004).  Importantly, we confirmed that in vivo VSV 
administration results in viral infection of both glial cell types in situ, while earlier 
studies demonstrated that microglia and astrocytes respond to VSV by proliferating, 
producing inducible nitric oxide synthase (iNOS), and increasing the expression of cell 
surface MHC class II molecules (Bi et al., 1995), responses that are likely to set the stage 
for subsequent inflammatory damage. 
An immune response to a virus in the CNS requires the recognition of this 
pathogen and the mechanisms by which innate immune cells achieve this have only 
recently become apparent with the discovery of a variety of cell surface and cytosolic 
molecules that serve as sensors for viral components.  Such pattern recognition receptors 
(PRRs) are present on and within immune sentinel cells and appear to bind conserved 
viral structures known as pathogen-associated molecular patterns (PAMPs).  These 
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PAMPs have several features that make them ideal targets for innate immune recognition.  
First, PAMPs are unique to microbes and viruses allowing for ‘self ’ versus ‘non-self’ 
recognition by the innate immune system.  Second, PAMPs are often conserved among 
similar pathogens allowing a relatively small number of PRRs to detect a broad array of 
challenges.  In addition, PAMPs tend to be essential for microbial/viral survival making 
pathogen evasion by mutation or deletion unlikely.   
PRR engagement by PAMPs can precipitate the production of anti-viral type I 
interferons (IFN) and/or the release of chemotactic and inflammatory molecules that can 
then direct a subsequent adaptive immune response.  Three families of PRRs have been 
defined: Toll-like receptors (TLRs), nucleotide oligomerization domain (NOD)-like 
receptors (NLRs), and retinoic acid inducible gene (RIG)-I-like receptors (RLRs).  As 
such, these molecules represent important mechanisms by which a protective host 
response or potentially damaging inflammation could be initiated (Kawai and Akira, 
2007; Yoneyama et al., 2010). 
1.2 TLRs mediate glial responses to extracellular or endosomal viral motifs 
Toll was first identified as a gene critical for fruit fly embryogenesis (Hashimoto 
et al., 1988) but its products were subsequently shown to play an important role in 
Drosophila’s immunity to fungal infections (Lemaitre et al., 1996).  Interestingly, similar 
gene products were found in mammalian cells and these Toll-like receptors have since 
been shown to play an important role in the initiation of innate immune responses to 
infection (Medzhitov et al., 1997).  To date, at least 13 TLRs have been discovered in 
mammals and members of this family of cell surface receptors can elicit inflammatory 
and/or anti-viral mediator production and can serve to initiate or modify adaptive immune 
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responses (as reviewed in Kawai and Akira, 2008).  Several TLRs have been 
demonstrated to specifically recognize viral motifs, including TLRs 2, 3, 7, 8, and 9.  
While TLR2 is best known to bind a variety of microbial cell wall component including 
lipoproteins, peptidoglycans, and lipoteichoic acid present in bacterial cell walls and 
zymosan, an integral yeast cell wall component, this sensor can also recognize yet-
identified viral motifs.  In contrast, endosomal TLRs such as TLR3 recognize viral 
double-stranded RNA (dsRNA) and its synthetic analog, polyinosine-deoxycytidylic acid 
(polyI:C), while TLR7 and TLR8 mediate responses to GU-rich single-stranded RNA 
(ssRNA) produced in virus-infected cells.  Finally, TLR9 detects bacterial and viral DNA 
with unmethylated CpG motifs.   
Importantly, studies from our group and others have demonstrated that both 
microglia and astrocytes express these cell surface/endosomal receptors for viral motifs, 
including TLR3 (Bsibsi et al., 2006; Jack et al., 2005) TLR7 (Jack et al., 2005), and 
TLR9 (Jack et al., 2005), either constitutively or following activation.  Upon ligand 
binding, TLRs dimerize and undergo conformational changes precipitating a complex 
cascade of intracellular signaling events that ultimately result in activation of 
transcription factors including nuclear factor- B (NF-κB), and interferon regulatory 
factors (IRF) 3 and 7 (as reviewed in Wilkins and Gale, 2010; Kawai and Akira, 2008). 
NF- B is a critical transcription factor in the regulation of inflammatory cytokine 
production, while IRF3 and IRF7 activation stimulates expression of antiviral genes 
including IFN-β.  Hence, activation of cells via these receptors can initiate the repertoire 
of defense mechanisms used by the innate immune system against viral pathogens. 
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TLR3 is perhaps the most widely studied PRR in the perception of viral 
pathogens by glial cells.  Isolated murine wild-type microglia are known to respond to the 
TLR3 ligand polyI:C by secreting TNF-  and IL-6 (Melton et al., 2003).  In line with 
these findings, intracerebral administration of poly(I:C) has been shown to elicit 
microglial (Melton et al., 2003, Town et al., 2006) and astrocyte (Melton et al., 2003) 
activation associated with neuronal loss, a response that is nearly absent in TLR3 
knockout animals (Town et al., 2006).  Circumstantial evidence for the involvement of 
TLR3 in encephalitis following RABV infection comes from the finding that the 
expression of this PRR is upregulated prior to the onset of lethal neuroinflammation 
(McKimmie et al., 2005). 
Several studies have also implicated TLR3 activation in WNV-associated 
pathogenicity.  Double stranded RNA, a ligand for TLR3, is produced by WNV during 
infection and has been shown to trigger the release of cytokines and chemokines from 
human microglia (Cheeran et al., 2005).  Seemingly in keeping with these observations, 
TLR3 deficient mice were found to be resistant to lethal WNV-associated encephalitis.  
The fulminate CNS inflammatory response seen in wild type mice, characterized in part 
by activated microglia, was markedly reduced or absent in knockout animals following 
intraperitoneal WNV infection (Wang and Fikrig, 2004).  However, this reduced CNS 
disease occurs despite increased peripheral viral loads and reduced systemic production 
of antiviral and proinflammatory cytokines (Wang et al., 2004).  These results suggest 
that decreased systemic inflammation in the absence of TLR3 expression may maintain 
blood-brain-barrier integrity and prevent WNV access into the CNS (Wang et al., 2004).  
Such a hypothesis is supported by the demonstration that direct intracerebral 
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administration of WNV leads to identical outcomes in wild type and TLR3 deficient mice 
(Wang et al., 2004).  However, it must be noted that at least one study appears to 
contradict this finding in that neuronal WNV replication was increased in TLR3 knockout 
animals following subcutaneous infection, and the reason for this apparent disparity is 
presently unclear (Daffis et al., 2008).   
Another endosome-associated PRR, TLR7 also appears to play an important role 
in inflammatory and/or protective glial responses to viral pathogens.  Intracerebral 
administration of the TLR7 agonist imiquimod leads to pronounced neuroinflammation, 
with upregulated expression of TNF- , IL-1β, IL-6, and IL-12 as well as the chemokines 
CCL2, CCL3, CXCL1, CXCL9, and CXCL10 (Butchi et al., 2008).  Interestingly 
however, this effect appears to be predominantly due to the activation of astrocytes rather 
than microglia (Butchi et al., 2008).  Upregulation of TLR7 has been demonstrated in the 
brains of infected mice prior to lethal RABV-induced inflammation (McKimmie et al., 
2005).  Furthermore, mice lacking the expression of myeloid differentiation primary 
response gene (MyD) 88, a critical downstream effector molecule of TLRs including 
TLR7, have increased susceptibility to an attenuated RABV strain and TLR7 deficient 
mice exhibited a phenotype with deficits in both the development of peripheral immunity 
and rabies virus clearance from the CNS (Li et al., 2011).  As such, these data indicate a 
possible role for TLR7 in viral clearance from infected brain tissue.  In contrast, another 
report has shown that macrophages isolated from TLR7 deficient animals had reduced 
IL-12 and IL-23 responses following in vitro WNV infection and TLR7 knockout mice 
demonstrated increased susceptibility to lethal WNV encephalitis (Town et al., 2009). 
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It has recently been shown that TLR2 contributes to detrimental inflammatory 
cytokine production following intracranial administration with HSV-1, with the absence 
of TLR2 expression leading to decreased peripheral (Kurt-Jones et al., 2004) and CNS 
(Aravalli et al., 2005) inflammatory responses and increased survival in mice.  In addition, 
multiple reports have shown that maximal in vitro microglial and astrocyte responses to 
HSV-1 are dependent on the presence of TLR2 (Aravalli et al., 2005; Lokensgard et al., 
2001; Schachtele et al., 2010; Wang et al., 2012) and HSV-1-infected microglia derived 
from TLR2 deficient mice have been demonstrated to elicit less neuronal oxidative 
damage and death in mixed neural cell cultures in comparison to infected wild-type 
microglia (Schachtele et al., 2010).  However, it should be noted that these studies differ 
in their assessments of the relative importance of this PRR in such responses, and marked 
elevations in serum IL-6 concentrations have been found in TLR2 deficient mice 
following HSV-1 infection (Kurt-Jones et al., 2004).  Together, these data suggest while 
TLR2 may play a major role in HSV-induced pathology and mortality, other possibly 
redundant mechanism(s) are likely to be involved. 
In addition to the detection of HSV virion motifs by TLR2, genomic HSV DNA 
can be recognized by TLR9 and at least one study suggests that this sensor might play a 
more significant role in lethal HSV-1 encephalitis than TLR2 (Lima et al., 2010).  In 
contrast, others have shown that the absence of TLR9 alone does not impact survival, 
type I IFN levels, or viral replication in the brain following HSV infection (Wang et al., 
2012).  However, it appears likely that these sensors could act in a cooperative or 
synergistic manner, as TLR2/9 double knockout mice show significantly greater 
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susceptibility to HSV-1 infection than mice deficient in either TLR2 or TLR9 alone 
(Lima et al., 2010).   
Taken together, this body of work suggests that TLR activation is a significant 
contributor to sustained glial activation, inflammatory mediator production, and neuronal 
loss during viral CNS infections.  However, it is important to note that TLRs can also 
mediate beneficial effects.  For example, the activation of glial cells via TLR2, 3, or 9 has 
been shown to initiate the production of type I IFNs (Conrady et al., 2010; de Diego et al., 
2010; Zhou et al., 2009) which limit viral replication through the induction of proteins 
such as RNase L and IFN-induced dsRNA-activated protein kinase, resulting in mRNA 
degradation and cessation of translation, respectively (Samuel et al., 2001).  However, the 
mechanisms that keep the balance between damaging and protective glial responses have 
not been identified and are likely to include a multitude of variables including the number 
of infectious organisms, the kinetics of glial activation and immune mediator production, 
the specific identity of the responsive glial cell, and the direct influence of the pathogen 
itself on the cellular response.  Moreover, evidence is accumulating that TLR expression 
is not limited to glial cells and that neurons can also express such PRRs under certain 
conditions (Cameron et al., 2007; Ma et al., 2006).  However, the functional relevance of 
TLR expression in neurons has not been resolved. 
While cell-surface receptors like TLRs appear to play an important role in glial 
responses to extracellular pathogens or those internalized into intracellular compartments, 
the ability of such cells to respond to pathogens in the absence of TLR expression 
suggests that additional mechanisms must be present.  Furthermore, our recent studies 
employing the model neurotropic RNA virus, VSV, demonstrate that viral replication is 
 14 
required to elicit robust immune responses by infected microglia and astrocytes, and 
indicate that mechanisms exist to sense the presence of replicative viral products within 
infected cells.  We have shown that heat inactivated wild-type VSV or a host-range VSV 
mutant that is replication impaired (Grdzelishvili et al., 2005) elicit glial immune 
responses that are an order of magnitude smaller than those induced by wild type viral 
particles (Chauhan et al., 2010).  These results suggest that VSV-induced glial responses 
are not predominantly mediated by cell surface and/or endosomal PRRs and suggest that 
active viral replication is a critical requirement for such responses.   
The recent demonstration that microglia and astrocytes express members of the 
newly described RLR family of PRRs may provide a mechanism underlying the 
replication-dependent nature of glial responses (Furr et al., 2008).  RLRs such as RIG-I 
and melanoma differentiation-associated gene 5 (MDA5) have been shown to serve as 
intracellular PRRs for viral nucleic acid motifs (Takeuchi and Akira, 2008; Kato et al., 
2006), and their involvement in inflammatory and antiviral responses in other cell types 
raises the intriguing possibility that these cytosolic sensors could play an important role 
in glial responses to viral infection.  However, the role of cytosolic PRRs in CNS 
inflammation has yet to be determined. 
1.3 RIG-like receptors can mediate protective immune responses and damaging  
CNS inflammation following RNA virus infection 
 
 In contrast to cell-surface TLRs, RLRs detect viral RNA motifs or processed self-
RNA in the cytoplasm to trigger innate immunity and inflammation. These intracellular 
sensors are responsible for the production of type I IFN in most cell types in response to 
RNA virus infection (Saito et al., 2007; Kato et al., 2006; Lui et al., 2007; Sumpter et al., 
2005), a notable exception being plasmacytoid dendritic cells.  In addition to such 
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antiviral responses, RLR engagement also elicits robust inflammatory cytokine 
production (Takeuchi and Akira, 2010).  Helicase interaction with viral RNA induces the 
recruitment of downstream effector molecules including interferon promoter stimulator 
(IPS)-1 (also known as VISA, Cardif or MAVS) which localizes to the mitochondrial 
membrane and/or to peroxisomes (Dixit et al., 2010), and TNF receptor associated factor 
(TRAF)3.  This leads to the subsequent activation of mitogen activated protein (MAP) 
kinases, and the IKK-related kinases, TRAF family member-associated NF- B activator 
(TANK) binding kinase 1 and IκB kinase (IKK)-I (as shown in Figure 1).  These kinases 
activate the transcription factors NF-κB and IRF3, which translocate into the nucleus and 
activate transcription of IFN stimulated genes and inflammatory cytokines.  RLRs are 
comprised of three domains:  N-terminal caspase activation and recruitment domains 
(CARDs), a helicase domain, and a C-terminal domain (CTD).  Although RIG-I and 
MDA5 may share similar signaling features (Yoneyama et al., 2005) and structural 
homology (Yoneyama et al., 2004), it is now known that the two helicases discriminate 
among different ligands to trigger the innate immune response to RNA viruses. 
Signaling by RIG-I is triggered during infection by a number of RNA viruses and 
by the presence of synthetic RNA transcribed in vitro (Saito et al., 2007; Kato et al., 
2006; Lui et al., 2007; Sumpter et al., 2005).  More recently, RIG-I has been implicated 
in the recognition of single stranded or double stranded RNA moieties that harbor 5′ 
triphosphate ends (5'ppp-ssRNA and 5'ppp-dsRNA, respectively) (Hornung et al., 2006; 
Pichlmair et al., 2006) or the detection of RNAs that assume complex secondary 
structures (Saito et al., 2007; Sumpter et al., 2005).  Other recent studies have elucidated 
the structural basis for activation of RIG-I by such RNA ligands.   Inactive RIG-I has an 
 16 
open conformation in which the CARD domains are sequestered by a helical domain 
inserted between the helicase moieties. When activated, ATP and RNA binding induce a 
major rearrangement in RIG-I to a closed conformation in which the helicase and CTD 
bind the blunt end 5'ppp-dsRNA with perfect complementarity (Kowalinski, 2011).   
In contrast, MDA5 has been reported to be more selective and is triggered during 
picornavirus infections or in the presence of poly(I:C) (Gitlin et al., 2006; Kato et al., 
2006; Loo et al., 2008).  The CTD domains of MDA5 and RIG-I involved in RNA 
binding have been suggested to be responsible for the differences in RNA binding 
affinity seen between these RLRs.  Each have a similar fold and a similar basic surface 
but distinct RNA binding loops exist within the CTD for RIG-I and MDA5, and 
conformation of this RNA binding loop seems to be responsible for sensitivity to dsRNA 
or 5'ppp-ssRNA. Mutation studies of the basic surface and the RNA binding loop support 
this conclusion, as well as other RLR structural studies (Takahasi et al., 2009; Li et al., 
2009). 
We have recently demonstrated that the expression of RIG-I and MDA5 is 
discernable in uninfected mouse brain tissue, and both show elevated expression 
following intranasal administration of VSV (Furr et al., 2008).  VSV is a neurotropic 
negative-sense single-stranded RNA virus that closely resembles rabies virus. In mice, 
intranasal VSV infection results in a severe encephalitis with rapid activation and 
proliferation of microglia and astrocytes (Huneycutt et al., 1993; Bi et al., 1995).  Our lab 
has previously demonstrated that isolated murine microglia and astrocytes constitutively 
express both RIG-I and MDA5 transcripts and protein, as well as the critical downstream 
effector molecule, IPS-1, and has shown that expression is elevated following challenge 
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with VSV (Furr et al., 2008).  Furthermore, the expression of these novel viral sensors 
has been confirmed in human astrocytoma cells (Yoshida et al., 2007). 
Some studies suggest that IPS-1 is essential for triggering protective innate and 
adaptive immunity against WNV in the CNS.  In these studies, mice deficient in the RLR 
adaptor molecule IPS-1 exhibited increased susceptibility to WNV infection, 
characterized by enhanced inflammation, viral replication and rapid dissemination into 
the CNS (Suthar et al., 2010).  However, it is important to note that glial cells were not 
the focus of this study and IPS-1 dependent IFN responses and limiting of viral 
replication was attributed to effects on systemically generated immune cells and cortical 
neurons, perhaps via changes in the numbers and/or function of regulatory T-cells (Suthar 
et al., 2010).  As such, these data suggest an innate/adaptive immune interface mediated 
through RLR signaling that regulates the balance of the immune response to WNV 
infection.  Together, these findings raise the exciting possibility that RLR molecules may 
play important roles in the detection of viral CNS pathogens, and depending upon the 
host cell type or particular viral pathogen, the initiation of protective immune responses 
or, alternatively, the progression of damaging inflammation within the brain.  However, 
the functional role of these molecules in glial responses to RNA viral pathogens within 
the CNS has not been explored 
1.4 Newly discovered cytosolic viral sensors may mediate glial responses to DNA  
viruses 
 
Recently, novel cytosolic DNA sensors have been discovered that include DNA-
dependent activator of interferon-regulatory factors (DAI; also known as Z-DNA binding 
protein 1) (Takaoka et al., 2007) and a DNA sensing inflammasome consisting of the 
HIN200 protein, absent in melanoma 2 (AIM2) (Schroder and Tschopp, 2010).  Acting in 
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concert with TLRs, these receptors may provide a diverse repertoire of mechanisms to 
alert the cell to viral and microbial DNA, leading to the activation of the innate immune 
system in a similar manner to that seen with RLR-mediated responses to viral RNA. DAI 
reportedly senses cytosolic DNA using two N-terminal Z-DNA binding domains (ZBDs) 
and a third putative DNA binding domain located next to the second ZBD.  The crystal 
structure of the DAI/Z-DNA complex reveals that DAI adopts an unusual binding mode 
for Z-DNA recognition (Ha et al., 2008).  The DAI ZBDs bind DNA and both must be 
bound for full B-to-Z conversion and so it conceivable that the binding of two DAI 
proteins to each cytoplasmic dsDNA elicits DAI dimerization and subsequent innate 
immune activation (Wang et al., 2008; Ha et al., 2008). 
Importantly, DAI has been shown to recognize double-stranded DNA in its 
canonical B helical form (B-DNA) (Takaoka et al., 2007) and elicit type-I IFN and 
inflammatory cytokine production in a TLR9-independent manner (Ishii et al., 2006; 
Stetson et al., 2007) in other cells types.  DAI elicits such immune functions via 
activation of the IRF and NF- B transcription factors.  DAI-induced IRF activation 
depends on TANK-binding kinase 1 (TBK1).  In contrast, DAI-induced NF- B activation 
is mediated through interactions between two receptor-interacting protein (RIP) 
homotypic interaction motifs (RHIMs) in the DAI protein and RHIM-containing kinases, 
RIP1 and RIP3 (Rebsamen et al., 2009; Kaiser et al., 2008) (as shown in Figure 2), as 
shown by the demonstration that knockdown of either RIP1 or RIP3 inhibits DAI-
induced NF- B activation.  Overexpression of DAI in mouse fibroblasts enhances DNA-
mediated type I IFN production while DAI knockdown attenuates responses to viral DNA 
(Takaoka et al., 2007).  In an additional study, DNA-mediated activation of NF-κB and 
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the induction of NF-κB-dependent genes and their products were also significantly 
inhibited in cells following DAI knockdown (Rebsamen et al., 2009).  As such, these data 
support a significant role for DAI in DNA-mediated activation of the NF-κB pathway and 
viral recognition.  However, it is interesting to note that DAI-mediated NF-κB activation 
appears to facilitate replication of HIV-1 although the mechanisms underlying this effect 
remain unclear (Hayashi et al., 2010).    The recent description of a molecule, stimulator 
of interferon genes (STING), that is essential for the recognition of intracellular DNA 
provides the possibility of a role for this protein in DAI-induced responses.  Interestingly, 
loss of STING renders mice susceptible to lethal infection with the DNA virus HSV-1 
(Ishikawa and Barber, 2008). 
Furthermore, unlike the RNA sensor RIG-I, DAI detects a structure common to 
both self and non-self DNA.  This suggests that the discrimination between these types of 
DNA is based on its subcellular localization, and may likely be a function of the amount 
and the length of the DNA present in the cytosol rather than a specific chemical feature of 
the ligand (as reviewed in Keating et al., 2011).   Interestingly, a recent study has shown 
that HSV-1 DNA, mislocated from the viral capsid, is readily detectable in the cytoplasm 
of infected RAW264.7 macrophages, bone marrow-derived macrophages (BMDMs), and 
THP-1 cells (Unterholzner et al., 2010).  However, it remains to be determined how 
detection of cellular DNA in the cytoplasm by this sensor is avoided.   
DAI has been reported to be constitutively expressed in the lymph nodes and 
spleen, although detectable levels are also found in circulating leukocytes and other 
tissues including bone marrow and small intestines (Rothenburg et al., 2002). To date, the 
 20 
functional expression of DAI by microglia and astrocytes and its involvement in innate 
immune responses to DNA viruses in the CNS have not been explored.  
1.5 PRRs act in a cooperative manner to induce glial responses to viral challenges  
While the preceding sections have focused on the roles of specific individual 
PRRs in the detection of viral pathogens by CNS cells, this narrow approach is fraught 
with peril.  It is highly likely that glial responses represent the sum of the inputs from 
disparate cell surface, endosomal, and cytosolic viral sensors.  It has been demonstrated 
that the level of expression of a particular TLR, NLR, or RLR by microglia and 
astrocytes can be regulated by ligands for dissimilar PRRs (Bowman et al., 2003; Jack et 
al., 2005; Carpentier et al., 2005).  Furthermore, mechanisms of positive and negative 
regulation of RLR signaling have been identified that include signaling crosstalk between 
RLR, NLR and DNA-sensing pathways, and caspase networks.  For example, it has been 
shown that mice deficient in the expression of the DNA-sensing downstream effector 
molecule STING (as shown in Figure 2) are highly susceptible to infection by negative-
stranded viruses including VSV suggesting a role for this signaling molecule in both DAI 
and RIG-I mediated cell activation (Ishikawa and Barber, 2008).  Immunoprecipitation 
studies indicate STING associates with RIG-I complexes in close proximity with 
endoplasmic reticulum associated mitochondria or possibly peroxisomes (Ishikawa et al., 
2009; Dixit et al., 2010) (as shown in Figure 1).  Furthermore, a number of RNA viruses 
including yellow fever virus, dengue virus, and hepatitis C virus, encode proteins with 
significant structural homology to STING and at least one of these proteins produced by 
the dengue virus has been shown to inhibit STING function (Ishikawa et al., 2009).  As 
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such, these observations suggest a role for STING in antiviral host responses to both 
DNA and RNA viruses.  
Interestingly, there have been recent reports of a role for the well-characterized 
bacterial sensor, NOD2, in the recognition of viral infections and the activation of IRF3 
via IPS-1 (Sabbah et al., 2009).  NOD2 is known to signal through the adaptor molecule 
RIP2 to trigger NF- B activation following recognition of muramyl dipeptide, a 
component of bacterial cell walls. In their study, Sabbah and colleagues (2009) suggested 
that this sensor was important in the detection of ssRNA derived from respiratory 
syncytial virus.  However, it is currently unknown whether NOD2 is directly activated by 
this viral ligand, or is activated secondarily following association with other PRRs or 
RNA binding factors.   
 Another example of crosstalk between viral sensing pathways is the recent 
demonstration that RIG-I may be important in the production of type I IFNs by cells in 
response to DNA viral challenge in a DNA-dependent RNA polymerase III manner 
(Ablasser et al., 2009; Chui et al., 2009).  In this described pathway, AT-rich double-
stranded DNA serves as a template for RNA polymerase III and is transcribed into RNA 
containing a 5'-triphosphate, the ligand for RIG-I.  Subsequent activation of RIG-I by this 
ligand has been shown to induce type I IFN production and to activate NF- B, and 
studies employing RNA polymerase III knockdown or pharmacological inhibitors of this 
enzyme have shown that this pathway is important in cell responses to the 
gammaherpesvirus Epstein-Barr virus (Ablasser et al., 2009; Chui et al., 2009).  These 
studies indicate that the transcription of cytosolic viral DNA by RNA polymerase III and 
subsequent RNA recognition by RIG-I may provide an additional mechanism for the 
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perception of DNA viruses by host cells.  Furthermore, it remains to be determined 
whether such interactions between other PRRs and RIG-I-associated signaling 
components occur in glial cells or whether they play a significant role during viral CNS 
infections.  
1.6  Hypothesis and present study 
 In the present study, we have tested the hypothesis that the activation of microglia 
and astrocytes in response to viral pathogens of the CNS is mediated by novel 
intracellular pattern recognition receptors, RIG-I and DAI.  As shown in Figure 3, the 
current body of knowledge concerning the sensors involved in pathogen recognition, the 
signaling pathways that result from activation, and the outcomes following viral infection 
in glial cells is very limited.   
Here, we demonstrate that primary murine microglia and murine/human 
astrocytes constitutively express detectable levels of the intracellular pattern recognition 
receptor, RIG-I, and show that such expression is elevated following exposure to a model 
neurotropic RNA virus, VSV. Evidence for the functional nature of RIG-I expression in 
these cells comes from the observation that this molecule associates with its downstream 
effector molecule, IPS-1, following VSV infection and from the finding that a specific 
ligand for RIG-I, 5’ppp-ssRNA, elicits significant inflammatory cytokine responses. 
Importantly, RIG-I knockdown significantly reduces this inflammatory cytokine 
production by VSV-infected human glia and inhibits the production of soluble neurotoxic 
mediators by these cells. These findings directly implicate RIG-I in the initiation of 
inflammatory immune responses by glial cells and provide a potential mechanism 
underlying the neuronal cell death associated with acute viral CNS infections. 
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In addition, we show that isolated microglia and astrocytes constitutively express 
DAI and its effector molecules RIP3 and STING, and show that such expression is 
upregulated following DNA virus challenge. We demonstrate that these resident CNS 
cells express DAI in situ, and show that its expression is similarly elevated in a murine 
model of HSV-1 encephalitis. Importantly, we show B-DNA transfection can elicit 
inflammatory cytokine production by isolated glial cells and DAI knockdown can 
significantly reduce microglial and astrocyte responses to HSV-1. Finally, we 
demonstrate that HSV-1 challenged microglia and astrocytes release neurotoxic 
mediators and show that such production is significantly attenuated following DAI 
knockdown.  Therefore, the functional expression of DAI by microglia and astrocytes 
may represent an important innate immune mechanism underlying the rapid and 
potentially lethal inflammation associated with neurotropic DNA virus infection. 
Interestingly, we show that glial inflammatory responses to the DNA virus HSV-1 
were also dependent on the expression of RIG-I and the activity of polymerase III, while 
glial responses to the RNA virus VSV required the expression of RIG-I but were DAI 
and polymerase III independent.  Collectively, these studies provide the first evidence 
that both RIG-I and DAI play a critical role in the recognition of viral pathogens by 
resident CNS cells and suggest that these novel intracellular pattern recognition receptors 
may underlie the damaging inflammation and neuronal cell death associated with acute 
neurotropic viral infections. 
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1.7 Figures 
 
 
FIGURE 1:  RLRs detect viral RNA motifs in the cytoplasm to trigger innate immunity 
and inflammation. MDA5 recognizes double-stranded RNA moieties (dsRNA), while 
RIG-I perceives short single or double-stranded RNAs with 5′ triphosphate ends (ppp-
ssRNA). Helicase interaction with these viral RNAs induces the recruitment of 
downstream effector molecules including mitochondrial- or peroxisomal-associated 
IPS-1 (also known as VISA, Cardif or MAVS), TRAF3, and/or STING, leading to the 
activation of IKK-related kinases, TBK1, and IKK-I.  These kinases activate the 
transcription factors NF-κB and IRF3, which translocate into the nucleus and activate 
transcription of antiviral and inflammatory cytokines.  
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FIGURE 2:  Recognition of DNA viruses by DAI.  DAI has been shown to detect viral or 
microbial double-stranded DNA (dsDNA) in the cytoplasm of infected cells, and elicit 
antiviral and inflammatory cytokine production.  DAI elicits such immune functions via 
possible interactions with mitochondrial- or peroxisomal-associated IPS-1, and/or STING, 
facilitating the activation of the IRF and NF-kB transcription factors.  DAI-induced IRF 
activation is dependent on TANK-binding kinase 1 (TBK1).  In contrast, DAI-induced 
NF- B activation is mediated through interactions involving RIP1 and RIP3. 
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FIGURE 3:  Possible pathways for viral detection by glial cells.  While these pathways 
have been explored and/or suggested in other cell types, it is currently unknown if these 
receptors, including RIG-I and DAI, are expressed or functional in glial cells.  In addition, 
the possibility that glial cells express newly discovered critical downstream adaptors such 
as STING and recently described pathways involving RNA polymerase III (Pol III) could 
provide additional mechanisms for the perception of DNA viruses by glial cells.  Finally, 
it remains to be determined whether the activation of these possible pathways results in 
damaging or protective immune responses, including the production of inflammatory 
cytokines.  
 
 
CHAPTER TWO:  MATERIALS AND METHODS 
 
 
2.1  Isolation of neonatal brain microglia and astrocytes  
 
 Briefly, six to eight neonatal C57 mouse brains per preparation were dissected 
free of meninges and large blood vessels and finely minced with sterile surgical scissors. 
The minced tissue was then forced through a wire screen and briefly incubated with 
0.01% trypsin–0.005% EDTA for 5 minutes. The cell suspension was then washed and 
this mixed glial culture was maintained in RPMI 1640 containing 10% fetal bovine serum 
(FBS) and gentamicin for 2 weeks. A microglia culture was obtained from this mixed 
glial culture by shaking flasks for 2 hours at 200 rpm in an orbital shaker (New 
Brunswick Scientific, Edison, NJ) and allowing the transferred dislodged cells to adhere 
to new tissue culture vessels for 1 hour. The media were then removed and fresh RPMI 
1640 with 10% FBS and 20% conditioned medium from LADMAC cells (ATCC, CRL-
2420) as a source of colony stimulating factor-1 was added to maintain microglia cultures 
for 1 week, while astrocytes were cultured in RPMI 1640 containing 10% FBS.  Cells 
isolated in this manner were >95% and >97% authentic microglia and astrocytes, 
respectively, as assessed by their characteristic morphology and by expression of the 
microglial/macrophage markers CD11b and F4/80 or the astrocyte marker glial fibrillary 
acidic protein (GFAP) as determined by immunofluorescent microscopy. All studies were 
performed in accordance with relevant federal guidelines and institutional policies 
regarding the use of animals for research purposes (IACUC Protocol # 11-010).
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2.2  Primary human astrocyte and human neuronal cell culture 
 Primary astrocytes isolated from human brain tissue were purchased from ScienCell 
(Carlsbad, CA).  Cells were maintained in a specially formulated medium supplemented 
with FBS, growth supplement, and penicillin/streptomycin solution, purchased from the 
supplier.  These commercially available cells have been characterized as authentic 
astrocytes by the vendor according to their expression of GFAP as determined by 
immunofluorescent analyses.  The human cortical neuron cell line, HCN-1A, was 
obtained from ATCC (CRL-10442; Manassas, VA).  Cells were maintained in 
Dulbecco’s modified Eagle’s media containing 10% FBS with penicillin and 
streptomycin. 
2.3  Preparation of viral stocks 
 VSV viral stocks were prepared by infecting monolayer cultures of baby hamster 
kidney epithelial cells (BHK-21; ATCC, CCL-10) with wild type VSV (Indiana strain) at 
a low multiplicity of infection (MOI) of 0.05 plaque-forming units (PFU) per cell and 
incubated for 48 hours at 34
o
C in SFM4MegaVir protein-free medium (Thermo Scientific 
Hyclone, Waltham, MA).  The cell-free medium containing released viruses was 
collected and viral titers were quantified using a standard plaque assay of serial dilutions 
of VSV on BHK-21 cells at 34
o
C.  VSV-GFP is VSV (Indiana strain) encoding green 
fluorescent protein as an extra gene between G and L genes (Das et al., 2006), and was 
kindly provided by Dr. Asit K. Pattnaik (University of Nebraska).  VSV-GFP was 
utilized to verify the absence of infectious particles in conditioned medium following 
filtration.  HSV-1 viral stocks were prepared by infecting monolayer cultures of Vero 
cells (ATCC; CCL-81) with HSV-1 (MacIntyre strain from a patient with encephalitis; 
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ATCC, VR-539) at a low multiplicity of infection (MOI) of 0.05 plaque-forming units 
(PFU) per cell and incubated for 48 hours at 34
o
C in SFM4MegaVir protein-free medium 
(Thermo Scientific Hyclone, Waltham, MA).  Cells were removed with trypsin and pulse 
sonicated (Vibra Cell; Sonics & Materials Inc., Newtown, CT) to release intact virions.  
The sonicated material was centrifuged to remove unwanted cellular debris and the viral 
titers in the cell-free supernatant was quantified using a standard plaque assay of serial 
dilutions of HSV-1 on Vero cells at 34
o
C.  MHV-68 viral stocks were prepared by 
infecting monolayer cultures of BHK-21 cells (ATCC, CCL-10) at a low viral MOI of 0.1 
PFU per cell. After 24 hours, the cells were removed with trypsin and pulse sonicated to 
release intact virions.  The sonicated material was centrifuged to remove unwanted 
cellular debris and the supernatant containing virus was aliquoted and stored at −80°C.  
The medium containing released virus was collected and viral titers were quantified using 
a standard plaque assay of threefold serial dilutions on NIH-3T3 cells at 34
o
C.  
2.4  In vitro HSV-1, MHV-68, and VSV infections 
Microglia and astrocytes were infected with HSV-1, MHV-68, or VSV at MOIs 
of 0.01, 0.1, 1, and 10 PFU per cell and the viruses were allowed to adsorb for 1 hour 
prior to washing to remove nonadherent viral particles.  Cultures were maintained for 12 
or 24 hours prior to collection of culture supernatants or preparation of whole cell protein 
isolates. 
2.5  In vivo HSV-1 infection 
 HSV-1 (MacIntyre strain) was administered to 4-6 week-old female C57BL/6 
mice (Jackson Laboratories) via intranasal (i.n.) infection essentially as described by our 
laboratory with other viral pathogens (Elsawa et al., 2003).  Anesthetized animals were 
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untreated or received i.n. HSV-1 administration (1 x 10
5 
- 1 x 10
6
 PFU) in PBS (final 
volume of 20 ul).  Animals were euthanized at 4 days post-infection and protein isolates 
were prepared from whole brain tissue homogenates or glial cells acutely isolated from 
infected and uninfected animals by flow cytometry as described below.  All studies were 
performed in accordance with relevant federal guidelines and institutional policies 
regarding the use of animals for research purposes (IACUC Protocol # 08-027). 
2.6  Acute isolation and cytometric analysis of CNS cells 
Mixed CNS cells were acutely isolated from infected and uninfected animals 
using a protocol modified from Campanella and coworkers (2003) as previously 
described (Chauhan et al., 2008).  Whole brains were rapidly removed and mechanically 
disrupted in a glass homogenizer, washed, and resuspended in PBS/30% Percoll (Fluka, 
Sigma Aldrich, St. Louis, MO) solution. This was overlaid on a gradient containing 37% 
and 70% Percoll solutions and centrifuged at 600 X G for 20 minutes at room 
temperature.  Glial cells were then collected from the interface and washed with PBS.  
Microglia/macrophages and astrocytes and were isolated from the mixed glial preparation 
by flow cytometry using an R-phycoerythrin conjugated monoclonal antibody directed 
against mouse CD11b (BD Biosciences, clone M1-70) and an AlexaFluor488-conjugated 
monoclonal antibody directed against mouse GFAP (Invitrogen, Eugene, OR, clone 131-
17719), respectively.  Protein isolates were prepared and analyzed for the presence of 
DAI, STING, RIP3, and viral gG1 by immunoblot analysis. 
2.7  Isolation of RNA and semi-quantitative reverse transcribed PCR 
Poly(A) + RNA was isolated from glial cells and reverse transcribed as previously 
described (Bowman et al., 2003).  Polymerase chain reactions (PCR) were performed to 
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determine the expression of mRNA encoding RIG-I.  Positive and negative strand PCR 
primers used, respectively, were 5’-GTGCAAAGCCTTGGCATGT-3’ and 5’-
TGGCTTGGGATGTGGTCTACTC-3’ to amplify mRNA encoding human RIG-1 
(115 bp fragment).  Primers were designed by using OligoCalc (Kibbe, 2007: 
www.basic.northwestern.edu/biotools/oligocalc.html) based on their location in different 
exons of the genomic sequence and their lack of significant homology to sequences 
present in GenBank (MacVector Sequence analysis software, IBI, New Haven, CT).  The 
identity of the PCR amplified fragments was verified by size comparison with DNA 
standards (Promega).  The input RNA was normalized to the expression of the 
housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (G3PDH). 
2.8  Nuclear and cytoplasmic protein extractions 
Nuclear and cytoplasmic protein extracts were prepared from human astrocytes by 
suspension in lysis buffer containing 10 mM KCl, 1.5 mM MgCl2, 10 mM HEPES, 0.5 
mM dithiothreitol (DTT), and protease inhibitor cocktail for 20 minutes at 4
o
C.  The 
nuclei and other fragments were then separated by centrifugation and supernatants were 
retained as cytoplasmic fractions.  Nuclei were lysed by exposure to a high salt buffer 
containing 420 mM NaCl, 15 mM MgCl2, 20 mM HEPES, 0.2 mM EDTA, 20% glycerol, 
0.5 mM phenylmethylsulphonylfluoride (PMSF), 1 mM DTT, 1% NP-40, and 2.5 ug/ml 
leupeptin for 20 minutes at 4
o
C.  Samples were then cleared of cellular debris by 
centrifugation and supernatants containing the nuclear fraction were collected. 
2.9  Western blot analyses for RIG-1, IPS-1, NF-B p65 (RelA), DAI, RIP3, STING,  
 and the HSV-1 gene product glycoprotein G-1 (gG1) 
 
Western blot analyses for the presence of RIG-1, IPS-1, NF-B, DAI, RIP3, and 
STING in glial cells or whole brain homogenates were performed as described previously 
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by our laboratory (Bowman et al., 2003).  After incubation with a rabbit polyclonal 
antibody against RIG-1 (Abgent, San Diego, CA), IPS-1 (Abcam, Cambridge, MA), the 
p65 (RelA) subunit of NF-kB (Millipore, Billerica, MA), DAI (Abcam, Cambridge, MA), 
RIP3 (Abcam, Cambridge, MA), STING (Abcam, Cambridge, MA), or a mouse 
monoclonal antibody against gG1 (Abnova, Taipei, Taiwan) for 24 hours at 4°C, blots 
were washed and incubated in the presence of an horseradish peroxidase (HRP)-
conjugated anti-rabbit antibody (Cell Signaling, Danvers, MA) or an HRP-conjugated 
anti-mouse antibody (Cell Signaling, Danvers, MA), respectively.  Bound enzyme was 
detected with the Super Signal system (Thermo Scientific, Rockford, IL).  To assess total 
protein loading in each well, immunoblots were reprobed with a goat anti-mouse -actin 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or the expression level of an 
unidentified non-specific protein present in Coomassie blue stained membranes was 
determined.  Immunoblots shown are representative of at least three separate 
experiments. 
2.10  Co-immunoprecipitation 
Briefly, human astrocytes (2 × 10
6
) infected with VSV were washed with ice-cold 
PBS and lysed at 4°C at 1 hour following infection in Tris-buffered saline with EDTA 
(150 mM NaCl, 5 mM EDTA, 20 mM Tris, pH 7.5) plus 1% Brij-97 (Sigma-Aldrich) and 
10 units/mL aprotinin (Calbiochem, San Diego, CA), 1 mM PMSF, and 1 ug/mL 
pepstatin A.  The lysates were incubated with protein A agarose beads (Pierce Endogen) 
conjugated with antibodies directed against IPS-1 for 18 hours at 4°C.  The 
immunoprecipitated material was subsequently subjected to immunoblot analysis for the 
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presence of RIG-I.  To assess total protein loading in each well, immunoblots were 
probed for the presence of total IPS-1 content in the immunoprecipitated material. 
2.11  In vitro stimulation of glial cells with the RIG-I ligand, 5’-triphosphate single  
stranded RNA 
 
To generate 5’-triphosphate single stranded RNA (5’ppp-ssRNA), we created a 
linear template for run-off in vitro transcription by digesting the pGEM-SeV-NP plasmid 
(previously described in Curran and Kolakofsky, 1991) with EcoRV.  EcoRV cuts 
pGEM-SeV-NP at a single site allowing a 342 base RNA to be generated when using the 
SP6 promoter.  RNA was generated using the MAXIscript In Vitro Transcription Kit 
(Ambion) at 37
o
C for 2.5 hours in a final volume of 200 ul containing approximately 1 ug 
of linearized pGEM-SeV-NP, all four NTPs, transcription buffer, and 200 U of SP6 
enzyme mix.  The reaction was then separated into two fractions and one was twice 
treated with 2 U calf intestinal alkaline phosphatase (CIAP; Promega) at 37
o
C for 15 
minutes to dephosphorylate the RNA for use as a negative control in our studies.  Both 
CIAP-treated and untreated RNAs were then incubated at 37
o
C for 20 minutes in the 
presence of 10 U Turbo DNase (Ambion) to remove the plasmid template.  Following 
addition of EDTA (35 mM), the samples were phenol/chloroform extracted and ethanol 
precipitated.  Precipitated RNA was resuspended in RNase free water to a final 
concentration of 200-250 ng/ul.  The final RNA products were analyzed by 
electrophoresis on a 2.5% agarose gel. 
5’ppp-ssRNA or dephosphorylated ssRNA was introduced intracellularly into 
human astrocytes using Tfx-20 transfection reagent (Promega) or into murine glial cells 
using FuGENE HD transfection reagent (Promega) at concentrations of 4 ug/ml and 8 
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ug/ml for one hour.  For comparison purposes, cells were exposed to transfection reagent 
alone or 5’ppp-ssRNA in the absence of transfection reagent.  
2.12  In vitro stimulation of glial cells with the DAI ligand, B-DNA 
 Poly(dA:dT) double-stranded B-DNA (InvivoGen, San Diego, CA) was directly 
introduced into microglia and astrocytes at concentrations of 3 ug/ml and 6 ug/ml using 
FuGENE HD Transfection Reagent (Promega, Madison, WI) according to the 
manufacturer’s instructions.   At 6 and 12 hours following transfection, culture 
supernatants and whole cell protein isolates were collected for analysis.   
2.13  siRNA-mediated knockdown of RIG-I and DAI 
 Three validated Stealth RNAi™ siRNA duplexes targeting human or murine RIG-
I, as well as universal negative control siRNA not homologous to anything in the 
vertebrate transcriptome, were purchased from Invitrogen (Carlsbad, CA).  Glial cells 
were transfected with each siRNA duplex individually or in concert using Tfx-20 
Reagent (Promega) or FuGENE HD transfection reagent (Promega) according to the 
manufacturer’s instructions.  Antibiotic-free media was replaced with complete media at 
6 hours following transfection.  At 24, 48 and 72 hours after transfection, whole cell 
lysates were collected for immunoblot analyses to confirm RIG-I expression knockdown. 
 Three validated Stealth RNAi™ siRNA duplexes targeting murine DAI, in 
addition to a universal negative control siRNA that was not homologous to anything in 
the vertebrate transcriptome, were purchased from Invitrogen (Carlsbad, CA).  Microglia 
and astrocytes were transfected with the siRNA duplexes using FuGENE HD transfection 
reagent.  Antibiotic-free media was replaced with complete media at 6 hours following 
transfection.  At 72 hours post-transfection, DAI knockdown was confirmed in whole cell 
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lysates by immunoblot analysis.  In some studies, double knockdown was achieved in 
glial cells by transfecting with both RIG-I and DAI siRNA duplexes described above, 
using FuGENE HD transfection reagent. 
2.14  Quantification of IL-6 and TNF- secretion in glial cell culture supernatants 
 Specific capture ELISAs were performed to quantify concentrations of IL-6 and 
TNF-.  A commercially available ELISA kit was used to measure murine TNF- (R&D 
Systems, Minneapolis, MN) secretion while murine IL-6 secretion was measured using a 
rat anti-mouse IL-6 capture antibody (Clone MP5-20F3) and a biotinylated rat anti-
mouse IL-6 detection antibody (Clone MP5-C2311) (BD Pharmingen, San Diego, CA).  
A commercially available ELISA kit (Ready-Set-Go!; eBioscience, San Diego, CA) was 
used to assay human TNF- levels according to the manufacturer’s instructions. A pair of 
capture and detection anti-human cytokine antibodies (BD Biosciences, San Diego, CA) 
was used to quantify IL-6 (clone MQ2-13A5 and biotinylated clone MQ2-39C3).  Bound 
antibody was detected by addition of streptavidin-horseradish peroxidase (BD 
Biosciences).  After addition of TMB substrate and H2SO4 stop solution, absorbances 
were measured at 450 nm.  A standard curve was constructed using varying dilutions of 
recombinant cytokines (BD Biosciences) and the cytokine content of culture supernatants 
determined by extrapolation of absorbances to the standard curve.   
2.15  Assessment of soluble neurotoxic mediator production by infected glial cells 
 Transfected or untransfected microglia and astrocytes were uninfected or infected 
with VSV or HSV-1 (MOI of 1 PFU per cell) for 1 hour prior to washing to remove non-
adherent viral particles.  At 24 hours following infection, the conditioned medium was 
collected and filtered using a 0.1-um syringe filter (Sterlitech, Kent,WA) to remove 
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residual VSV (0.1 to 0.4 mm in length) or HSV-1 particles (180 – 200 nm in diameter) 
prior to addition to resting HCN-1A human neuronal cells or CATH.a murine neuron-like 
cell cultures (ATCC #CRL-11179).  Our ability to remove all infectious viral particles 
from the conditioned medium was verified in parallel experiments by demonstrating the 
exclusion of the smaller VSV (0.1-0.4 nm in length) engineered to express green 
fluorescent protein.  At 4, 8, and 12 hours following filtered conditioned medium 
addition, the numbers of adherent HCN-1A or CATH.a cells were counted in ten 
microscopy fields and viability was assessed by trypan blue exclusion. 
2.16  RNA polymerase III inhibition 
 Glial cells were pre-treated with 10 U (300 pmol) of Tagetin™ RNA Polymerase 
inhibitor (Epicentre Biotechnologies) for 10 hours.  Following treatment, cells were 
either infected with VSV (MOI of 10) for 12 hours or transfected with siRNA against 
DAI for 72 hours, then infected with HSV-1 (MOI of 10) for 12 hours. 
2.17  Densitometric analyses 
 Densitometric analyses of immunoblots were performed using ImageJ (obtained 
from the NIH Web site http://rsbweb.nih.gov/ij/download.html).  Results are presented as 
mean values of arbitrary densitometric units corrected for background intensity 
normalized to the expression of -actin or irrelevant proteins, or as fold increases over 
levels in unstimulated cells. 
2.18  Statistical analyses 
Results of the present studies were tested statistically by ANOVA and Tukey’s post hoc 
test using commercially available software (SAS Institute, Cary, NC).  In all experiments, 
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results were considered statistically significant when a P-value of less than 0.05 was 
obtained.  
 
 
CHAPTER THREE:  A ROLE FOR DNA-DEPENDENT ACTIVATOR OF 
INTERFERON REGULATORY FACTOR IN THE RECOGNITION 
OF HERPES SIMPLEX VIRUS TYPE 1 BY GLIAL CELLS 
 
 
3.1  Rationale 
 
 The neurotropic DNA virus HSV-1 is capable of causing severe necrotizing 
encephalitis and accounts for 95% of all fatal cases of sporadic viral encephalitis (Xu et 
al., 2006).  Untreated HSV-1 encephalitis has a 70% mortality rate and patients who 
receive early treatment have only a 40% chance of recovery without significant 
neurological deficits.  Furthermore, the overall mortality rate of HSV-1 encephalitis in 
the US remains at 30% despite improvements in diagnosis and therapy (Baringer, 2008).  
It has recently been shown that HSV-1-mediated cytokine and chemokine production 
contributes to CNS damage following in vivo infection suggesting that an overzealous 
host response is a major contributor to the neuropathology associated with acute viral 
encephalitis (Nakajima et al., 2001; Rosler et al., 1998; Wildemann et al., 1997).  
However, the mechanisms underlying the onset of such damaging neuroinflammation 
have not been defined. 
 The rapid onset of inflammation following CNS infection suggests that resident 
glial cells play a pivotal role in the initiation and progression of encephalitis.  Microglia 
and astrocytes are resident cells of the CNS cells and are susceptible to HSV-1 infection 
(Aravalli et al., 2006).  Both of these cell types are now recognized to have innate 
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immune functions and respond to invading pathogens by producing soluble mediators 
that can promote inflammation and leukocyte recruitment across the blood-brain barrier 
(Konat et al., 2006; Carpentier et al., 2005; Falsig et al., 2008). Importantly, microglia 
have been shown to produce significant levels of the proinflammatory cytokines TNF-  
and IL-6 in response to HSV-1 infection (Lokensgard et al., 2007).  While host immune 
cells have been shown to recognize HSV-1 or HSV-2 via cell-surface or endosomal 
pattern recognition receptors including TLR2 and TLR9 (Lund et al., 2003; Kurt-Jones et 
al., 2004), the means by which resident CNS cells perceive DNA virus infection and 
initiate inflammatory cytokine production have not been defined. 
 Recently, the cytosolic protein, DAI (also known as Z-DNA-binding protein 1 
(ZBP1)), has been reported to function as an innate sensor of intracellular viral DNA (Fu 
et al., 1999; Ishii et al., 2006; Takaoka et al., 2007; Wang et al., 2008).  This molecule 
has been shown to recognize double-stranded DNA in its canonical B helical form (B-
DNA) (Takaoka et al., 2007; Wang et al., 2008) and elicit type-I IFN production in a 
TANK-binding kinase 1 and IRF3 dependent, but TLR9-independent, manner (Ishii et 
al., 2006; Stetson et al., 2006).  Importantly, this cytosolic sensor has been reported to 
mediate type I IFN and inflammatory cytokine production by HSV-1-infected murine 
fibroblasts (Takaoka et al., 2007).  To date, DAI expression has not been reported in 
microglia or astrocytes, and a role for this putative viral sensor in the innate immune 
responses of resident CNS cells to viral challenge has not been explored. 
In the present study, we provide the first demonstration of constitutive and 
inducible expression of DAI and its downstream effector molecules by glial cells both in 
vitro and in situ.  Importantly, we confirm the functional status of DAI in primary 
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microglia and astrocytes and demonstrate that this viral sensor plays a significant role in 
the inflammatory and neurotoxic responses of resident CNS cells to HSV-1 challenge. 
 3.2  Results 
To determine whether resident CNS cells express DAI, we have assessed the 
expression of this cytoplasmic viral sensor in isolated primary murine microglia and 
astrocyte cultures.  As shown in Figure 4, both microglia and astrocytes constitutively 
express detectable levels of DAI as determined by immunoblot analysis although it is 
noteworthy that resting astrocytes demonstrated higher expression levels than that seen in 
equal numbers of microglia.  Interestingly, HSV-1 elicited an upregulation in microglial 
DAI expression by up to 23.8 fold over that seen in resting cells (Figure 4A).  Similarly, 
despite robust constitutive expression, HSV-1 exposure was able to further increase DAI 
expression in astrocytes with a maximal increase of 2.2 fold over that seen in 
unstimulated cells (Figure 4B).  Interestingly, the ability of viral challenge to augment 
DAI expression by primary glial cells was not limited to this neurotropic 
alphaherpesvirus as the lymphotropic (Flano et al., 2002) gammaherpesvirus, MHV-68, 
was also capable of eliciting robust increases in microglial DAI expression (Figure 4A) 
and causing modest increases in the expression of this molecule in astrocytes (7.3-fold) 
(Figure 4B). 
 Finally, to begin to determine whether DAI is functional in glial cells we have 
investigated whether these cells express RIP3 and STING, two critical downstream 
effector molecules in DAI signaling (Rebsamen et al., 2009; Ishikawa et al., 2009; 
Ishikawa and Barber, 2008). As shown in Figure 4C, both microglia and astrocytes 
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constitutively express robust levels of RIP3 and STING that were not significantly 
enhanced in either cell type following viral challenge. 
 To determine if glial cells express DAI in situ, we first assessed the expression of 
this viral sensor in microglia/macrophages and astrocytes acutely isolated from brain 
tissue of uninfected mice.  As shown in Figure 5A, whole brain homogenates 
constitutively expressed robust levels of DAI.  Interestingly, both GFAP+ astrocytes and 
CD11b+ microglia/macrophages isolated from uninfected brain tissue demonstrated only 
very low DAI expression levels (Figure 5B).  This apparent discrepancy suggested that 
other major CNS cell types, such as neurons, might constitutively express DAI and this 
hypothesis was supported by the observation that resting CATH.a neuron-like cells 
expressed high levels of this molecule (Figure 5A). 
 Furthermore, we assessed glial DAI expression following in vivo HSV-1 
infection.  To confirm that intranasal HSV-1 administration results in in situ infection of 
glial cells, we first determined the expression of HSV-1 glycoprotein G1 (gG1) in 
microglia and astrocytes acutely isolated from infected and sham-infected mice.  As 
shown in Figure 5C, robust levels of this HSV-1 gene product was readily detectable in 
glial cells isolated from the brains of infected animals, with astrocytes exhibiting higher 
levels of protein than microglia/macrophages, while it was absent in cells derived from 
sham infected mice.  Importantly, in vivo HSV-1 challenge elicited marked increases in 
DAI expression in both microglia/macrophages (24.8 fold) and astrocytes (8.5 fold) 
acutely isolated from the brains of infected animals (Figure 5B) in the absence of 
significant increases in levels of this viral sensor in total brain protein isolates (Figure 
5A).  Finally, we have assessed the expression of the DAI downstream effector molecules 
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RIP3 and STING in glia isolated from HSV-1 infected and sham infected mice.  As 
shown in Figure 5D, microglia/macrophages and astrocytes acutely isolated from 
uninfected brain tissue showed detectable levels of RIP3 and STING.  Consistent with 
our in vitro findings, in vivo HSV-1 infection failed to elicit significant changes in RIP3 
expression by either cell type.  Interestingly, and in contrast to our studies in cultured 
cells, STING expression was significantly elevated in both microglia/macrophages and 
astrocytes following in vivo HSV-1 infection (Figure 5D).  
 To begin to determine whether DAI is functional in glial cells, we have assessed 
the sensitivity of isolated cultures of astrocytes and microglia to intracellular 
administration of B-DNA, a DAI ligand.  As shown in Figure 6, B-DNA administration 
induced production of the inflammatory cytokines TNF-  and IL-6 by primary microglia 
or astrocytes as rapidly as 6 hours post-transfection at levels that matched or exceeded 
those elicited following 24-hour HSV-1 challenge. 
 To confirm the functional status of DAI in glial cells and to begin to determine 
the relative importance of this innate immune sensor in their responses to neurotropic 
DNS viruses we have assessed the effect of DAI knockdown on inflammatory cytokine 
production by HSV-1 challenged microglia and astrocytes.  As shown in Figure 7A, 
siRNA directed against DAI specifically and markedly inhibited HSV-induced TNF-
production by murine microglia.  Surprisingly, such an approach was not as effective in 
reducing cytokine production by astrocytes and only elicited a statistically significant 
reduction in TNF-  production at the highest viral MOI used (Figure 7B). 
 To begin to establish a role for DAI in the inflammatory CNS damage associated 
with neurotropic DNA viral infections, we have assessed the effect of DAI knockdown 
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on the production of soluble neurotoxic mediators by microglia and astrocytes following 
HSV-1 infection.  As shown in Figure 8A, HSV-1 induced the production of soluble 
mediators by microglia that decreased CATH.a neuron-like cell viability as assessed by 
changes in cell attachment and trypan blue exclusion in an MOI and time dependent 
manner.   Importantly, virally-induced neurotoxic mediator production was significantly 
attenuated in cells transfected with siRNA targeting DAI (-DAI) as compared to control 
cells that were transfected with scrambled non-specific siRNA (+DAI) (Figure 8A).  
Interestingly, HSV-infected primary astrocytes also produced a substance that elicited 
neuronal detachment and death, and production of such neurotoxic mediators was 
similarly attenuated in cells transfected with siRNA targeting DAI (Figure 8B).  
Together, these data point to a key role for DAI in the neurotoxic immune responses of 
microglia and astrocytes to DNA virus infection and may represent an important 
component in the inflammation and damage associated with viral encephalitis. 
3.3  Conclusions 
 Several members of the herpesvirus family including human herpesvirus 6, HSV-
1, and HSV-2 can elicit damaging CNS inflammation (Baringer, 2008; Isaacson et al., 
2005).  Acute HSV -1 infection or the reactivation of latent virus in the trigeminal nerve 
can lead to the development of severe encephalitis that is associated with a high degree of 
morbidity and mortality.  While acyclovir is currently employed in the treatment of HSV 
encephalitis, drug-resistant strains of HSV-1 are beginning to emerge (Whitley et al., 
1986; Kimberlin et al., 2007) and, despite improvements in diagnosis, such infections are 
associated with a 30% mortality rate and 62% of survivors recover with severe 
neurological deficits (Whitley et al., 1986; Raschilas et al., 2002; Hjalmarsson et al., 
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2007).  The treatment of HSV-1 associated encephalitis is especially challenging due to 
the rapid onset of disease and development of irreversible neurological damage in 
otherwise healthy individuals.  These characteristics suggest that the innate immune 
responses of resident CNS cells play a pivotal role in disease progression, a notion that is 
supported by the ability of human microglia to produce key inflammatory mediators in 
response to in vitro HSV challenge or following in vivo infection (Lokensgard et al., 
2001; Marques et al., 2004; Marques et al., 2008). However, much of our current 
understanding of HSV-1 encephalitis pathogenesis comes from rodent models in which 
intranasal HSV-1 administration results in an acute necrotizing encephalitis that closely 
resembles human disease (Mori et al., 2005; Ikemoto et al., 1995; Esiri et al., 1995; 
Mansur et al., 2005; Nair et al., 2007).  In these models, HSV-1 infects both neurons and 
glial cells and elicits inflammatory mediator production that precedes leukocyte 
infiltration into the CNS (Mori et al., 2005; Beers et al., 1995).  Such findings are 
consistent with the recognized ability of other viral pathogens to induce inflammatory 
cytokine production by microglia (Mariani et al., 2009), and the susceptibility and 
responsiveness of astrocytes to productive HSV-1 infection (Aravalli et al., 2006; Dix et 
al., 1992).  However, the mechanisms by which resident CNS cells recognize DNA viral 
pathogens such as HSV-1 have not been fully defined. 
 We and others have demonstrated that microglia and astrocytes express an array 
of cell surface and endosomal innate pattern recognition receptors, including TLR2 
(Konat et al., 2006), TLR3 (Bsibsi et al., 2006; Jack et al., 2005), TLR7 (Jack et al., 
2005), and TLR9 (Jack et al., 2005), that are capable of recognizing viral motifs (as 
reviewed in Kumar et al., 2011).  Importantly, roles for each of these cell surface sensors 
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have been described in the perception of HSV by a variety of cell types (Lund et al., 
2003; Kurt-Jones et al., 2004; Zhang et al., 2007; Wilkins et al., 2010).  However, it is 
becoming increasingly apparent that cells such as glia possess intracellular sensors that 
can detect when the cytosolic compartment has been compromised.  Our lab has 
previously demonstrated that murine cells functionally express RIG-I and MDA5 (Furr et 
al., 2008), two members of the RIG-I-like family of helicases that have been shown to 
function as intracellular pattern recognition receptors for replicative viral RNA motifs 
(Kumar et al., 2011; Wilkins et al., 2010).  It is possible that such receptors may also 
indirectly serve as sensors for viral and/or bacterial DNA via the actions of RNA 
polymerase III (Ablasser et al., 2009) although a role for this pathway in HSV 
recognition by immune cells remains controversial (Melchjorsen et al., 2010).  
Interestingly, a number of cytosolic proteins including DAI have been described that can 
directly mediate cellular responses to dsDNA (Takaoka et al., 2007; Wilkins et al., 2010).  
It has therefore been suggested that such sensors could play a critical role in the 
perception of viral DNA and this notion has been supported by the report that DAI 
mediates immune molecule production by HSV-1-infected murine fibroblasts (Takaoka 
et al., 2007).   
 In the present study, we provide the first evidence that glial cells express DAI.  
Resting cultures of primary microglia expressed low levels of this intracellular viral 
sensor, a finding that is consistent with the very low DAI expression observed in acutely 
isolated ex vivo microglia.  In contrast, astrocytes in culture constitutively expressed 
robust levels of this molecule, although it should be noted that this might be attributable, 
in part, to our in vitro culture conditions, as astrocytes acutely isolated from uninfected 
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mice expressed somewhat lower DAI levels.  Importantly, DAI expression was 
significantly elevated in microglia and astrocytes following either in vitro or in vivo 
HSV-1 challenge.  Such upregulation was not specific to this neurotropic 
alphaherpesvirus as the leukotropic gammaherpesvirus, MHV-68, was also capable of 
elevating DAI expression by both cell types.  As such, it is possible that glial perception 
of DNA viruses via this sensor could promote further DAI expression in a feed-forward 
manner.   
The constitutive expression of this viral sensor by glial cells and its upregulation 
following viral challenge provide circumstantial evidence of a role for DAI in glial 
responses to DNA viral pathogens.  This notion is further supported by the robust 
constitutive expression in microglia and astrocytes of IPS-1 (Furr et al., 2008), STING, 
and RIP3, molecules reported to serve as downstream effector molecules for DAI 
(Rebsamen et al., 2009; Ishikawa and Barber, 2009).  Importantly, we have confirmed 
that DAI is functional in primary murine glia by showing that cytoplasmic administration 
of the DAI ligand, B-DNA, is a potent stimulus for the production of key inflammatory 
mediators by both microglia and astrocytes.  Finally, we have demonstrated a major role 
for this intracellular viral sensor in the immune responses of primary murine microglia to 
a clinically relevant neurotropic DNA virus by demonstrating that DAI knockdown 
specifically and significantly inhibits HSV-1-induced cytokine production by this CNS 
sentinel cell.  Interestingly, while B-DNA administration elicits robust inflammatory 
cytokine production by astrocytes comparable to similarly stimulated microglia, DAI 
knockdown was far less effective in attenuating HSV-induced cytokine production by 
astrocytes.  While the reason for this difference is presently unclear, it is possible that the 
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siRNA approach employed did not sufficiently reduce the high DAI levels seen in 
cultured astrocytes.  However, this appears unlikely due to the ability of siRNA directed 
against DAI to significantly reduce the production of neurotoxic substance(s) by 
astrocytes.  Alternatively, these results could be due to the presence of redundant viral 
sensor mechanisms in astrocytes, but not microglia, that are capable of perceiving this 
DNA virus. 
 Host responses to viral CNS infections are increasingly recognized to play a 
major role in disease pathology and the neuroinflammation elicited by HSV-1 has been 
suggested to underlie the neurological damage associated with infection (Nakajima et al., 
2001; Rosler et al., 1998; Wildemann et al., 1997).  However, it not clear whether this 
inflammatory damage is mediated primarily by infiltrating leukocytes or by the responses 
of the resident cells of the CNS themselves.  In support of the latter possibility, activated 
glial cells are known to be capable of producing toxic mediators that can cause 
widespread CNS damage (Marques et al., 2008).  Furthermore, the rapidity with which 
HSV-1 travels from the initial site of infection to the brain all but assures escape from 
recognition by adaptive immune cells.  Based on these observations, it appears likely that 
the production of cytotoxic substances by HSV-1 challenged glial cells could play a 
significant role in neuronal cell dysfunction and/or loss and contribute to the 
neuropathology associated with HSV-1 encephalitis.  In the present study, we have 
demonstrated that soluble factor(s) released by HSV-infected microglia and astrocytes 
elicit neuronal cell damage/death and that the production of this factor(s) is dependent, at 
least in part, on the expression of DAI.  
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3.4  Figures 
 
 
 
FIGURE 4:  Cultured primary murine astrocytes and microglia constitutively express the 
cytoplasmic viral sensor DAI and associated effector molecules, and its expression is 
elevated following viral challenge.  Cultured microglia (Panels A and C) or astrocytes 
(Panels B and C) were untreated (0) or infected with HSV-1 (MOI of 0.1, 1 and 10) or 
MHV-68 (MOI of 1 and 10).  At 24 hours post-infection expression of DAI (Panels A 
and B), RIP3 and STING (Panel C) were determined in whole cell lysates by immunoblot 
analysis.  Representative results are shown for one of three separate experiments. 
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FIGURE 5:  Ex vivo glial cells express DAI constitutively and/or inducibly following in 
vivo HSV-1 infection.  Mice were sham-infected (0) or infected with HSV-1 (HSV: 1 x 
10
5
 PFU, i.n.).  At 4 days post-infection protein isolates were prepared from whole brain 
tissue (Brain), or microglia (Mg) or astrocytes (Ast) acutely isolated by flow cytometry, 
and analyzed for the presence of DAI (Panels A and B), viral gG1 (Panel C), RIP3 and 
STING (Panel D) by immunoblot analysis.  For comparison purposes, DAI expression in 
the murine neuron-like cell line CATH.a (Panel A: Cath) and murine small intestine 
tissue (Panels A and B: +), or viral gG1 expression in HSV-1 infected Vero cells (Panel 
C: +)  is shown.  Immunoblots shown are representative of three separate experiments. 
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FIGURE 6:  A specific ligand for DAI induces inflammatory cytokine production by 
isolated cultures of microglia and astrocytes.  Microglia (Panel A) and astrocytes (Panel 
B) were untreated (0), treated with transfection reagent alone (FG), or transfected with 
the DAI ligand B-DNA (3 or 6 ug/ml).  At 6 and 12 hours following transfection culture 
supernatants were collected and IL-6 and TNF-  content was assessed by specific 
capture ELISA.  For comparison purposes inflammatory cytokine production was 
assessed at 24 hours following HSV-1 infection (MOI of 1 and 10).  Data is expressed as 
mean +/- SEM (n = 6) and an asterisk indicates a statistically significant difference from 
levels produced by unstimulated cells (p < 0.05).   
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FIGURE 7:  DAI knockdown attenuates HSV-1-induced inflammatory cytokine 
production by murine glial cells.  Microglia (Panel A) and astrocytes (Panel B) were 
untreated (0), or transfected with siRNA targeting DAI (-DAI) or scrambled siRNA 
(+DAI).  At 72 hours following transfection, cells were exposed to HSV-1 (MOI of 0.01, 
0.1, 1, and 10) and levels of TNF-  in the culture supernatants were assessed at 24 hours 
post- - SEM (n = 3) and an asterisk indicates a 
statistically significant difference from levels produced by cells treated with scrambled 
siRNA (p < 0.05). 
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FIGURE 8:  HSV-1 induces the production of soluble factor(s) by glial cells that elicits 
neuronal cell damage in a DAI dependent manner.  Primary microglia (Panel A) or 
astrocytes (Panel B) were untreated (0) or transfected with siRNA targeting DAI (-DAI) 
or scrambled siRNA (+DAI).  At 72 hours following the transfection protocol, cells were 
uninfected or infected with HSV-1 (MOI of 1) and cultured for a further 24 hours.  
Filtered conditioned media from these cells was placed on CATH.a cells and the number 
of attached cells was monitored at 4, 8 and 12 hours post-infection prior to assessment of 
cell death by trypan blue exclusion at 12 hours post-infection.  Data is expressed as mean 
+/- SEM (n = 3).  Asterisks indicate a statistically significant difference in the number of 
attached cells or degree of cell death from that seen in unstimulated cells while pound 
symbols indicate a statistically significant difference in these parameters between cells 
treated with siRNA directed against DAI and those that received scrambled siRNA (p < 
0.05).  
 
 
CHAPTER FOUR:  RIG-I MEDIATES NONSEGMENTED NEGATIVE-SENSE 
RNAVIRUS-INDUCED INFLAMMATORY RESPONSES OF 
PRIMARY HUMAN ASTROCYTES 
 
 
4.1  Rationale 
 
The order Mononegavirales includes numerous etiological agents of important 
human viral diseases, including rabies, Ebola, Marburg, Nipah and Hendra viruses.  
Interestingly, members of this order include medically important pathogens with CNS 
involvement such as RABV and measles virus (Fishbein et al., 1993).  Virally induced 
CNS inflammation can be initiated by the elevated expression of key soluble 
inflammatory mediators including two cytokines, TNF-  and IL-6.  Importantly, elevated 
TNF-  (Nuovo et al., 2005; Solanki et al., 2009) and IL-6 (Phares et al., 2006) expression 
in the CNS has been reported following RNA virus infection and TNF-  has been 
implicated as a key factor in the pathogenesis of such infections (Camelo et al., 2000; 
Nuovo et al., 2005).  Like RABV, VSV is a negative-sense single-stranded RNA virus 
belonging to the Rhabdoviridae family.  VSV has the ability to infect neurons and 
generate acute encephalitis in mice (Huneycutt et al., 1993) and has therefore proven to 
be a useful model for this and other non-segmented, negative-sense RNA viruses.  As 
described in work by Dr. Carol Reiss and others (Bi et al., 1995; Lundh et al., 1987; 
1990; Miyoshi et al., 1971), intranasal inoculation of VSV in mice leads to infection of 
the olfactory bulb via the olfactory neurons and subsequently spreads throughout the 
CNS.   This infection is associated with acute encephalitis, breakdown of the blood-brain 
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barrier, and a high degree of mortality (Honeycutt et al., 1993).  Interestingly, VSV-
induced encephalitis appears to be T-cell independent, having been observed in athymic 
mice after viral administration (Frei et al, 1989). As such, it is likely that the innate 
immune functions of resident CNS cells play an important role in the rapid inflammatory 
response following VSV infection. 
There is growing appreciation that astrocytes can initiate and augment 
inflammation following infection (as reviewed in Dong and Benveniste, 2001).  These 
glial cells are activated at the site of challenge and assume immune effector functions, 
including the production of TNF-  and IL-6 (Streit et al., 1998).  Various RNA viruses 
have been reported to infect human and murine astrocytes in vitro (Ray et al., 1997) and 
in vivo (Garg et al., 2008; Wong et al., 2009), and the presence of RABV and Hendra 
virus antigens have been observed in astrocytes following in vivo infection (Jogai et al., 
2000; Wong et al., 2009).  Similarly, we have recently demonstrated that VSV can infect 
and replicate within cultured primary murine astrocytes (Chauhan et al., 2010).  
Astrocytes appear to respond to VSV as the encephalitis caused by this virus is associated 
with proliferation of this cell type and increased MHC class II molecule expression on 
their cell surface (Bi et al., 1995).  Furthermore, we have demonstrated that astrocytes 
express TNF-  and IL-6 following challenge with VSV, and that such cytokine 
production is dependent on the active replication of this virus within these cells  
(Chauhan et al., 2010).  While the ability of astrocytes to be infected by and respond to 
non-segmented negative-sense RNA viruses has been established, the mechanisms 
underlying the subsequent activation of this resident CNS cell type have not been 
defined. 
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Recently, a newly described group of molecules have been shown to function as 
intracellular sensors for replicative viral RNA (Takeuchi and Akira, 2007; Yoneyama et 
al, 2004; Yoneyama and Fujita, 2007).  A member of the retinoic acid-inducible gene 
(RIG)-I like receptor (RLR) family, RIG-I is a soluble protein found in the cytosol of 
many cell types and has been shown to mediate innate immune responses to viral RNA.  
Responses initiated via this cytosolic sensor include the production of antiviral cytokines 
as well as proinflammatory cytokines such as TNF-  and IL-6  (as reviewed in Meylan 
and Tschopp, 2006, and Rehwinkel and Reis e Sousa, 2010).  Genomic RNA from 
several viruses in the order Mononegavirales, including VSV, has been demonstrated to 
specifically activate immune responses via RIG-I (Kato et al., 2006).   Importantly, our 
lab has previously demonstrated that murine astrocytes express RIG-I in conjunction with 
its downstream effector molecule, IPS-1 (Furr et al., 2008).  In the present study, we 
demonstrate that primary human astrocytes express RIG-I and we show that such 
expression is inducible.  Importantly, we show that this cytosolic viral sensor is 
functional in these glial cells by demonstrating that a reported RNA ligand for this 
receptor can initiate inflammatory mediator production.  Finally, we have utilized 
silencing RNA (siRNA) techniques to begin to define the functional significance of RIG-
I expression in primary human astrocytes and its role in encephalitis caused by non-
segmented, negative-sense RNA viruses. 
4.2  Results 
To determine whether primary human astrocytes express this newly described 
viral pattern recognition receptor, we have assessed the level of RIG-I mRNA expression 
in cultures of these cells at rest and following challenge with VSV.  Human astrocytes 
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were untreated or exposed to VSV at varying MOIs prior to RNA isolation at 4 and 8 
hours post-infection (p.i.).  Semi-quantitative RT-PCR was performed to assess the 
presence of mRNA encoding RIG-I.  As shown in Figure 9A, astrocytes constitutively 
express mRNA encoding RIG-I.  Interestingly, such expression is rapidly elevated at 4 
hours p.i. but such elevations are transient and are not apparent at 8 hours p.i. (Figure 
9A). 
To determine whether the presence of mRNA encoding this RLR in human 
astrocytes translates to protein expression, immunoblot analyses were performed to 
assess RIG-I protein levels.  As shown in Figure 9B and as consistent with RIG-I mRNA 
expression, human astrocytes constitutively express detectable levels of RIG-I protein.  
Furthermore, exposure of astrocytes to VSV elicits elevations in the expression of this 
receptor as rapidly as 6 hours p.i with a maximal 3.3 fold induction at a MOI of 10 
PFU/cell as determined by densitometric analysis.  Importantly, constitutive RIG-I 
expression and subsequent VSV-induced elevations in such expression are restricted to 
the cytoplasm, and there is an absence of any detectable RIG-I protein in the nucleus of 
these cells (Figure 10) consistent with its role as a cytoplasmic viral pattern recognition 
receptor. 
To begin to determine whether RIG-I is functional in human astrocytes, we have 
investigated whether these cells express IPS-1, a critical downstream effector molecule in 
RIG-I signaling (Kumar et al, 2006).  As shown in Figure 11A, while astrocytes 
constitutively express robust levels of IPS-1, VSV does not significantly elevate IPS-1 
expression at any MOI of VSV at 12 hours (Figure 11A) p.i.  Next, we examined whether 
RIG-I interacts with IPS-1 following viral challenge using co-immunoprecipitation 
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techniques.  As shown in Figure 11B, infection of human astrocytes with VSV induces 
association of RIG-I with IPS-1 within one hour of infection. 
Interaction of RIG-I with IPS-1 has been previously demonstrated to elicit 
activation of the pivotal inflammatory transcription factor NF- B in other cell types (Lui 
et al., 2008).  We have therefore correlated the observed interaction of RIG-I and IPS-1 
with activation of NF- B in human astrocytes as assessed by the nuclear translocation of 
the NF- B p65 (RelA) subunit.  As shown in Figure 11C, infection of human astrocytes 
with VSV elicits nuclear translocation of RelA at 1-2 hours p.i.  Such rapid responses are 
consistent with the constitutive expression of both RIG-I and IPS-1 in these primary glial 
cells as demonstrated in Figures 9 and 11A. 
 Viral genomes have been reported to serve as the major trigger for RIG-I in cells 
infected with negative-sense single-stranded RNA viruses (Rehwinkel et al., 2010) 
confirming earlier suggestions that ssRNAs bearing 5′-ppp generated in vitro, perhaps 
with base-pairing at the 5’-end, are effective agonists for RIG-I (Hornung et al., 2006 and 
Pichlmair et al., 2006).  Consistent with this notion, treatment with calf intestinal 
phosphatase, which removes 5′-phosphates, has been shown to abolish stimulatory 
activity (Hornung et al., 2006 and Pichlmair et al., 2006).  To confirm the functional 
nature of RIG-I expression in primary human astrocytes, we have investigated the effects 
of intracellular administration of in vitro generated uncapped 5’ppp-ssRNA.  As shown in 
Figure 12A, administration of 5’ppp-ssRNA elicits significant increases in levels of 
mRNA encoding RIG-I.   Similarly, this ligand induces a modest but discernable 
elevation in RIG-I protein levels over those seen in cells that received only the 
transfection reagent (1.6 fold), an effect that was not seen in cells transfected with a 
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control dephosphorylated ssRNA (Figure 12B).  Interestingly, and in agreement with the 
effects of VSV (Figure 11A), 5’ppp-ssRNA fails to consistently elicit increases in IPS-1 
expression (Figure 12C).  While IPS-1 levels decreased with increasing concentrations of 
5’ppp-ssRNA, this effect does not appear to be specific as dephosphorylated ssRNA 
similarly decreased IPS-1 with increasing concentrations (Figure 12C). 
 Furthermore, we have determined that 5’ppp-ssRNA can elicit inflammatory 
immune responses in primary human astrocytes.  As shown in Figure 13A, 5’ppp-ssRNA 
induces nuclear translocation of NF- B (RelA) in a dose dependent manner.  Such NF-
B activation is consistent with the ability of this ligand to induce the production of the 
key inflammatory cytokines IL-6 (Figure 13B) and TNF-  (Figure 13C).  Importantly, 
these effects were significantly attenuated when the ligand was dephosphorylated 
(Figures 13B and C), consistent with the specific recognition of 5’ppp-ssRNA by RIG-I.  
Taken together, these data indicate that RIG-I is functionally expressed in primary human 
astrocytes and recognizes replicative viral RNA motifs. 
To begin to establish the relative importance of RIG-I in the initiation of VSV-
mediated astrocytes immune responses, we employed silencing RNA techniques to knock 
down the expression of this viral sensor.  As shown in Figure 14A, the use of a 
combination of three siRNA duplex oligomers effectively knocked down the expression 
of RIG-I in a time dependent manner with a maximal reduction observed at 72 hours 
post-transfection.  We then optimized our knockdown protocol by selecting the most 
effective siRNA duplex (DDX58-HSS177513; Invitrogen) for use in our subsequent 
studies (Figure 14B; duplex 3).  Importantly, we determined that transfection of human 
astrocytes with this siRNA duplex significantly inhibited VSV-induced inflammatory 
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cytokine production relative to that produced by cells transfected with non-specific 
scrambled siRNA (Figure 14C).  Together, these data indicate that RIG-I is an important 
component in the initiation of inflammatory immune responses of human astrocytes to 
negative sense single-stranded RNA virus challenge. 
To begin to establish a role for RIG-I in the inflammatory CNS damage 
associated with neurotropic non-segmented, negative-sense RNA viral infections, we 
have assessed the effect of RIG-I knockdown of the production of soluble mediators that 
can elicit neuronal cell death by VSV-infected human astrocytes.  As shown in Figure 
15A, VSV induces the production of soluble mediators by primary human astrocytes that 
can elicit decreases in the viability of HCN-1A human neuronal-like cells, as assessed by 
changes in cell attachment and trypan blue exclusion, in a MOI and time dependent 
manner.   Importantly, the virally-induced production of such neurotoxic mediators was 
significantly attenuated in cells transfected with siRNA targeting RIG-I (-R) as compared 
to control cells that were transfected with scrambled non-specific siRNA (+R) (Figure 
15B).  Together, these data point to a key role for RIG-I in the inflammatory immune 
responses of human astrocytes to non-segmented, negative-sense RNA viral infection and 
may represent a key component in the inflammation and damage associated with virally 
induced encephalitis. 
4.3  Conclusions 
The order Mononegavirales consists of viruses containing a non-segmented, 
negative-sense RNA genome and includes the causative agents for a number of 
established (rabies, measles, mumps) and emerging (Ebola, Borna, Hendra, Nipah) 
human diseases (Pringle, 1997).  Some members of this order, such as RABV and 
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Newcastle disease virus, have the ability to circumvent the blood-brain barrier to 
establish CNS infection resulting in a severe and often fatal inflammation of brain tissue 
(Leung et al., 2007; Seal et al., 2000).  VSV has proven to be a useful model for 
neurotropic non-segmented, negative-sense RNA viruses that cause human CNS 
infections due to its ability to gain access to the CNS and to elicit acute encephalitis 
(Honeycutt et al., 1993).  VSV-associated CNS inflammation is rapid, occurring within 
days of intranasal inoculation (Honeycutt et al., 1993), and this rapid onset is indicative 
of an innate immune response that is likely to involve resident CNS cells.  Such a 
hypothesis is supported by the observation that astrocytes exhibit immune functions in 
situ following VSV infection (Bi et al., 1995; Honeycutt et al., 1993; Leung et al., 2007).  
In a recent study we have demonstrated that isolated murine astrocytes produce key 
soluble inflammatory mediators including the cytokines TNF-  and IL-6 following 
exposure to VSV, and that such production is dependent upon the ability of this virus to 
replicate within the cytoplasm of these cells (Chauhan et al., 2010).  The recent 
description of RLRs, cytosolic DExD/H box RNA helicases that can recognize early viral 
replicative intermediates (Takeuchi and Akira, 2007), raises the intriguing possibility that 
such molecules could play an important role in the detection of RNA viruses by 
astrocytes. 
 In the present study, we describe the expression of RIG-I, an RLR that serves as 
an intracellular viral sensor, in primary cultures of human astrocytes.  We show that these 
cells constitutively express robust levels of mRNA encoding RIG-I.  Importantly, we 
demonstrate detectable levels of these proteins in resting astrocytes and we show that 
such expression is restricted to the cytoplasm of these cells.  These data are in agreement 
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with a recent study demonstrating the expression of mRNA encoding RIG-I and the 
detection of RIG-I protein in human astrocytoma cells, and the presence of RIG-I protein 
in uninfected primary human astrocytes as determined by immunocytochemical 
techniques (Yoshida et al., 2007).  In addition, the present studies are consistent with our 
recent demonstration that primary murine astrocytes constitutively express this RLR 
(Furr et al., 2008).  Interestingly, we show that the expression of RIG-I in primary human 
astrocytes is induced following infection with the model RNA virus, VSV.  Levels of 
mRNA encoding this RLR and the expression of this receptor protein in the cytoplasm 
are elevated following VSV infection.  Importantly, the present study provides the first 
demonstration that intracellular administration of in vitro generated 5’ppp-ssRNA, a 
reported ligand for RIG-I, induces RIG-I expression in primary human astrocytes.  As 
such, the present demonstration of robust levels of RIG-I in resting human astrocytes is 
consistent with the ability of these cells to mount rapid inflammatory immune responses 
following viral challenge.  Furthermore, the inducible nature of such expression by intact 
viral particles and a specific ligand for RIG-I suggests that astrocytes may become 
sensitized to the presence of intracellular viral motifs generated during viral replication in 
a feed-forward manner. 
 Perhaps more importantly, in the present study we provide the first demonstration 
that this RLR plays an important role in the inflammatory immune responses of 
astrocytes to infection with a non-segmented, negative-sense RNA virus.  First, we have 
demonstrated that primary human astrocytes constitutively express robust levels of IPS-1, 
a critical downstream adaptor molecule for RIG-I signaling.  The caspase activation and 
recruitment domains, or CARDs, of RIG-I interact with IPS-1 to induce type I interferon 
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gene expression in mouse embryonic fibroblasts via TRAF3 and IRF3/IRF-7 pathways 
(Kumar et al., 2006), and activate NF- B in a caspase-8 and 10-dependent manner to 
induce inflammatory cytokine production in immune cells such as macrophages (Hiscott, 
2007).  Consistent with this mechanism of action, we have demonstrated that exposure of 
human astrocytes to VSV initiates an association between RIG-I and IPS-1, and we have 
shown that viral challenge induces the translocation of the RelA subunit of NF- B to the 
nucleus in this cell type.  Furthermore, we have demonstrated that 5’ppp-ssRNA 
delivered intracellularly into primary human astrocytes similarly elicits NF-kB activation 
and inflammatory cytokine production.  We have confirmed the specificity of the actions 
of this RIG-I ligand by demonstrating that dephosphorylated RNA oligomers fail to elicit 
such marked cytokine responses.  Finally, we have confirmed a role for this intracellular 
viral sensor in the immune responses of primary human astrocytes to this model 
neurotropic rhabdovirus by demonstrating that RIG-I knockdown specifically and 
significantly inhibits VSV-induced cytokine production. 
 Neuronal loss has been reported in the CNS in human cases of RABV (Juntrakul 
et al., 2005) Hendra virus (Wong et al., 2009), and measles virus (Garg et al., 2008; 
McQuaid et al., 1997) infection.  However, at least one study has indicated that 
rhabdoviruses do not have an intrinsic ability to induce apoptosis in isolated neuron-like 
cells (Baloul and Lafon, 2003) suggesting that these viruses elicit neuronal cell death in 
an indirect manner.  Similarly, the pathogenesis of measles virus infection in the CNS has 
been suggested to result from neuronal apoptosis occurring either as a direct result of 
viral infection or as an indirect consequence of cytokine-mediated effects (McQuaid et 
al., 1997).  Interestingly, the level of cytotoxic factors including TNF-  has been found 
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to correlate with alterations in neuronal function and CNS damage in a murine model of 
RABV infection (Marquette et al., 1996), and a high level of TNF-  has also been 
associated with poor prognosis in patients with other acute viral encephalopathies (Anlar 
et al., 2001; Ravi et al., 1997).  In the present study, we have demonstrated that human 
astrocytes express marked levels of TNF-  in response to VSV, and such production 
occurs in a RIG-I dependent manner.  Furthermore, we have shown that soluble factors 
released by VSV-infected human astrocytes elicits cell damage/death of a human 
neuronal cell line and that the production of these factors is dependent on the expression 
of RIG-I.  These findings directly implicate RIG-I in the initiation of inflammatory 
immune responses by human glial cells and provide a potential mechanism underlying 
the neuronal cell loss associated with acute viral CNS infections. 
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4.4  Figures 
 
 
 
FIGURE 9:  Primary human astrocytes constitutively express the cytoplasmic viral RNA 
sensor, RIG-I, and such expression is elevated following viral challenge. Panel A: 
Cultured astrocytes (2 X 10
6
) were untreated (0) or infected with VSV (MOI of 0.01, 0.1, 
1, and 10).  At 4 and 8 hours p.i., RNA was isolated and semi-quantitative PCR was 
performed to determine the level of expression of mRNA encoding RIG-I or the 
housekeeping gene, G3PDH (G3).  For comparison purposes, RIG-I mRNA levels in a 
similar number of HeLa cells are shown (+).  Representative results of three separate 
experiments are shown.  Panel B:  Cultured astrocytes (2 X 10
6
) were untreated (0) or 
infected with VSV (MOI of 0.01, 0.1, 1, and 10).  At 6 and 24 hours p.i., RIG-I protein 
expression was determined in whole cell lysates by immunoblot analyses.  A 
representative immunoblot of protein isolates prepared at 6 hours p.i. is shown in the 
upper panel, and the average densitometric values of three separate experiments at 6 and 
24 hours p.i. normalized to b-actin expression is shown below.  Data is expressed as 
mean +/- SEM and an asterisk indicates a statistically significant difference from 
uninfected cells (p < 0.05).  For comparison purposes, RIG-I protein expression in a 
similar number of resting HeLa cells is shown in the representative immunoblot (+).   
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FIGURE 10:  RIG-I expression and subsequent VSV-induced elevations in such 
expression are restricted to the cytoplasm.  Cultured astrocytes (2 X 10
6
) were untreated 
(0) or infected with VSV (MOI of 0.1, 1, and 10).  At 12 hours p.i., nuclear and 
cytoplasmic extracts were prepared and RIG-I expression was assessed in each by 
immunoblot analysis.  For comparison purposes, RIG-I protein expression in HeLa cells 
is shown (+).  A representative blot of three separate experiments is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
 
FIGURE 11:  VSV induces the activation of RIG-I associated signaling pathways in 
primary human astrocytes. Panel A:  Cells (2 X 10
6
) were untreated (0) or infected with 
VSV (MOI of 0.01, 0.1, 1, and 10).  At 12 hours p.i., expression of the RIG-I downstream 
effector molecule IPS-1, was determined in whole cell protein isolates by immunoblot 
analysis.   IPS-1 expression in HeLa cells (+) is shown for comparison purposes.  Panel 
B:  Cells (2 X 10
6
) were untreated (0) or infected with VSV (MOI of 1 and 10).  At 1 
hour p.i., whole cell protein isolates were prepared and immunoprecipitated using beads 
coated with antibodies directed against IPS-1 prior immunoblot blot analysis for the 
presence of RIG-I.  RIG-I content in samples following the pre-clearing step (pc) is 
shown as a control and RIG-I expression in a similar number of resting HeLa cells is 
shown (+) for comparison purposes.  Representative results are shown for one of three 
separate experiments.  The relative level of RIG-I/IPS-1 complex formation in this 
experiment was determined by densitometric analysis normalized to total IPS-1 content 
in the precipitated material and is shown below the immunoblot.  Panel C:  Cells (2 X 
10
6
) were untreated (0) or infected with VSV (MOI of 0.1, 1, and 10).  At 1 and 2 hours 
p.i., nuclear (NUC) and cytoplasmic (CYT) extracts were prepared and NF-kB expression 
was determined by immunoblot analysis.  A representative blot of three separate 
experiments is shown. 
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FIGURE 12:  5’ triphosphate single stranded RNA, a specific ligand for RIG-I, 
upregulates RIG-I expression but not IPS-1 in primary human astrocytes.  Panel A: Cells 
(2 X 10
6
) were untreated (0) or exposed to 5’ triphosphate ssRNA (5’ppp-ssRNA: 4 or 8 
ug/ml) in the presence of Tfx-20 transfection reagent.  At 2 hrs following transfection, 
RNA was isolated and PCR was performed to determine the level of expression of 
mRNA encoding RIG-I and G3PDH.  For comparison purposes, RIG-I mRNA levels in a 
similar number of resting HeLa cells are shown (+).  Representative results of three 
separate experiments are shown.  Panel B: Cells (2 X 10
6
) were treated with Tfx-20 
transfection reagent alone (0) or exposed to 5’ triphosphate ssRNA (ppp:  4 or 8 ug/ml) or 
unphosphorylated RNA (-p: 4 or 8 ug/ml).  At 6 hours following transfection, RIG-I 
protein expression was assessed in whole cell lysates by immunoblot analysis.  For 
comparison purposes, RIG-I protein expression in a similar number of resting HeLa cells 
is shown (+).  Representative results are shown for one of three separate experiments and 
densitometric analysis of this experiment normalized to b-actin expression is shown 
below the immunoblot.  Panel C: Cells (2 X 10
6
) were untreated (0) or exposed to 5’ 
triphosphate ssRNA (ppp:  2, 4, or 8 ug/ml) or unphosphorylated ssRNA (-p: 2, 4, or 8 
ug/ml) as a control in the presence of Tfx-20 transfection reagent or without the addition 
of the transfection reagent (-Tfx).  At 6 hours following transfection, IPS-1 protein 
expression was determined in whole cell lysates by immunoblot analyses.  Representative 
results are shown of one of three separate experiments 
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FIGURE 13:  5’ triphosphate 
single stranded RNA, a specific 
ligand for RIG-I, induces NF-kB 
activation and inflammatory 
cytokine production in primary 
human astrocytes.  Panel A: Cells 
(2 X 10
6
) were untreated (0) or 
exposed to 5’ triphosphate 
ssRNA (5’ppp-ssRNA: 2 or 4 
ug/ml) in the presence of Tfx-20 
transfection reagent.  At 1 hour 
following transfection, nuclear 
and cytoplasmic extracts were 
prepared and RelA levels in each 
were assessed by immunoblot 
analysis.  Panels B and C: Cells 
(2 X 10
6
) were exposed to tri-
phosphorylated (ppp) or 
dephosphorylated (-p) 
recombinant ssRNA (ssRNA; 2, 
4, or 8 ug/ml) in the presence of 
Tfx-20 transfection reagent, or 
were unstimulated in the 
presence (+) or absence (-) of 
Tfx-20 alone.  At 6 hrs following 
transfection, supernatants were 
collected and IL-6 (Panel B) and 
TNF-  (Panel C) levels were 
measured by ELISA analyses.  
Data is expressed as mean +/- 
SEM (n = 6).  An asterisk 
indicates a statistically significant 
difference from unstimulated 
cells, pound symbol indicates a 
statistically significant difference 
from the equivalent concentration of dephosphorylated RNA, and asperand indicates a 
statistically significant difference from the preceding lower dose of each stimulus (p < 
0.05). 
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FIGURE 14:  RIG-I knockdown attenuates VSV-induced inflammatory cytokine 
production by primary human astrocytes.  Panel A: To determine knockdown efficiency, 
cells were untreated (0) or transfected with a combination of three different siRNA 
oligonucleotide pairs targeting RIG-I and cultured for 24, 48, or 72 hours prior to 
immunoblot analysis for the presence of RIG-I and the housekeeping gene product, -
actin.  Panel B: To verify the effectiveness of the siRNA oligonucleotide pairs, cells were 
untreated (0) or transfected with each siRNA pair (1, 2, or 3), or a combination of the 
three (All), and cultured for 72 hours prior to immunoblot analysis for the presence of 
RIG-I and -actin.  The relative level of RIG-I in astrocytes transfected with scrambled 
siRNA (-) is shown for comparison purposes.  Panel C: Cells were untreated (0), or 
transfected with one siRNA pair (pair 3) targeting RIG-I (RIGI siRNA) or scrambled 
siRNA (Control siRNA).  At 72 hours following transfection, cells were infected with 
VSV (MOI of 0.01, 0.1, 1, and 10) and the levels of TNF-  in the culture supernatants 
were assayed by specific capture ELISA at 12 hours p.i.  Data is expressed as mean +/- 
SEM (n = 3).  An asterisk indicates a statistically significant difference from unstimulated 
cells; a pound symbol indicates a statistically significant difference between cells 
transfected with siRNA directed against RIG-I versus scrambled siRNA (p < 0.05). 
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FIGURE 15:  VSV induces the production of a soluble factor(s) by human astrocytes that 
elicit neuronal cell death in a RIG-I dependent manner.  Panel A: Human astrocytes were 
untreated (0) or infected with VSV (MOI of 0.01, 0.1, 1, and 10).  At 24 hours p.i., 
filtered conditioned media from these infected cells or media spiked with recombinant 
TNF-  (63 pg/ml; TNF) was placed on HCN-1A cells.  Changes in viability of these 
human neuronal-like cells were assessed at 4, 8 and 12 hours by quantification of cell 
attachment and at 12 hours by trypan blue exclusion.  Panel B: Human astrocytes were 
untreated (0) or transfected with siRNA targeting RIG-I (-R) or scrambled siRNA (+R).  
At 72 hours following the transfection protocol, cells were uninfected or infected with 
VSV (MOI of 1) and cultured for a further 24 hours.  Filtered conditioned media from 
these cells was placed on HCN-1A cells.  As a positive control, media was spiked with 
recombinant TNF-  (63 pg/ml; TNF) and placed on HCN-1A cells.  Changes in viability 
of these human neuronal-like cells were assessed at 4, 8 and 12 hours by quantification of 
cell attachment and at 12 hours by trypan blue exclusion.  For comparison purposes, cell 
death of HCN-1A cells was assessed following exposure to conditioned medium from 
untransfected astrocytes infected with VSV (1).  Data is expressed as mean +/- SEM (n = 
3).  An asterisk indicates a statistically significant difference from unstimulated cells; a 
pound symbol indicates a statistically significant difference between cells transfected 
with siRNA directed against RIG-I versus scrambled siRNA (p < 0.05). 
CHAPTER FIVE:  RIG-I IS AN ESSENTIAL COMPONENT IN MURINE GLIAL 
RESPONSES TO NEUROTROPIC RNA AND DNA VIRUSES 
 
 
5.1 Rationale 
 
Viral infections in the CNS are known to broadly trigger glial cell activation and 
the subsequent release of proinflammatory molecules. For example, microglia have been 
shown to respond to DNA viruses such as herpes simplex virus (HSV)-I (Aravalli et al., 
2005; Lokensgard et al., 2001) and RNA viruses including West Nile Virus (WNV) 
(Cheeran et al., 2005, van Marle et al., 2007), by secreting various proinflammatory and 
chemotactic molecules.   However, the mechanisms underlying such glial responses to 
viruses have not been fully elucidated.  Viruses are sensed almost exclusively by their 
nucleic acid genomes, typically as a result of their transcriptional and/or replicative 
activity.  Two disparate PRRs, retinoic acid inducible gene (RIG)-I and DNA-dependent 
activator of interferon regulatory factors (DAI), have been identified that serve as sensors 
for different classes of viruses.  RIG-I senses the 5'-triphosphate moiety of negative-sense 
single-stranded RNA (ssRNA) viruses (Hornung et al., 2006; Pichlmair et al., 2006) or 
short blunt-ended double-stranded RNA (dsRNA) (Takahasi et al., 2008).  Subsequent 
ligation of RIG-I by either of these RNA moieties triggers downstream signaling and 
activation of the NF- B and/or IRF3 pathway(s), which induce the production of 
proinflammatory cytokines and type I IFNs, respectively.  In addition to viral RNA 
motifs, DNA is also a potent activator of innate immunity (Stetson & Medzhitov,
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2006).  DAI has been shown to bind synthetic dsDNA, B-DNA, and activate NF- B and 
IRF3 to promote the transcription of inflammatory and antiviral genes (Takaoka et al., 
2007; Ishii et al., 2006) similar to the RIG-I pathway.  Our previous studies demonstrated 
that isolated murine microglia and astrocytes constitutively express inducible levels of 
RIG-I and DAI.  In addition, we have shown that intracellular administration of the 
specific ligand for RIG-I elicits significant inflammatory mediator production, while 
targeted knockdown of RIG-I abolishes such responses following exposure to VSV and 
limits the production of soluble neurotoxic mediators by virally challenged human 
astrocytes.  In murine glial cells, recent studies from our lab have also established a 
similar functional role for DAI-dependent inflammatory and neurotoxic responses to the 
DNA virus HSV-1.  Together, this indicates a critical role for RIG-I and DAI in host 
responses to RNA viruses and DNA viruses in the CNS, respectively.  
Interestingly, recent studies suggest that RIG-I may also be able to recognize 
DNA pathogens in a polymerase III-dependent manner (Ablasser et al., 2009, Chui et al., 
2009).  In this pathway, AT-rich dsDNA serves as a template for RNA polymerase III, 
and is transcribed into RNA containing a 5'-triphosphate, the ligand for RIG-I.  
Activation of RIG-I by dsDNA has been shown to induce type I IFN production and NF-
B activation indicating that RNA polymerase III and RIG-I may provide another 
mechanism by which cells can sense viral DNA.  In the present study, we provide the 
first demonstration that RIG-I is functional in murine microglia and astrocytes and plays 
an essential role in glial responses to the neurotropic RNA virus VSV.  Furthermore, we 
have determined that this viral sensor and RNA polymerase III are essential for DAI-
dependent inflammatory immune responses of glia to the DNA virus HSV-1.  Taken 
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together, the present study indicates that RIG-I plays a significant role in the 
inflammatory responses of resident CNS cells to both RNA and DNA viral challenges. 
5.2 Results 
We have previously reported the ability of primary murine microglia and 
astrocytes to express the novel viral RNA sensor, RIG-I (Furr et al., 2008).  Furthermore, 
we have also shown that RIG-I is elevated following challenge with disparate RNA 
viruses (Furr et al., 2008).  To begin to establish the functional nature of RIG-I in murine 
glia (Furr et al., 2008) we have investigated the effects of the RIG-I specific ligand, 
uncapped 5’ppp-ssRNA (Hornung et al., 2006; Saito and Gale., 2008; Takahasi et al, 
2008), on the level of expression of this receptor.  As shown in Figure 16A, intracellular 
administration of 5’ppp-ssRNA elicits a significant increase in RIG-I protein levels in 
microglia over that seen in unstimulated cells.   Similarly, this ligand induces a modest 
but discernable elevation in RIG-I protein levels in murine astrocytes (Figure 16A).  
To determine whether RIG-I induction is restricted to RNA viruses and a RIG-I 
specific ligand, we investigated the effects of the DNA virus, HSV-1, on RIG-I 
expression.  As shown in Figure 17B, RIG-I levels were significantly enhanced in 
microglia as early as 12 hours post-infection.  HSV-1 also elevated RIG-I expression in 
murine astrocytes albeit with slower kinetics of induction (Figure 17C) with significant 
upregulation at all MOIs used at 24 hours following infection.  Finally, we have assessed 
the effect of a DNA virus-associated nucleic acid on RIG-I expression by primary murine 
glial cells.  B-DNA is a double-stranded DNA in its canonical B helical form, and is the 
putative ligand of DAI (Takaoka et al, 2007; Wang et al, 2008).  As shown in Figure 
17D, intracellular B-DNA administration resulted in marked elevations in RIG-I 
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expression in both microglia and astrocytes.  Together, these data indicate that RIG-I 
expression is not only induced by its own ligand, but can also be upregulated via 
disparate viral sensors. 
 To further assess the functional role of RIG-I, we have determined the ability of 
5’ppp-ssRNA to elicit inflammatory immune responses by both glial cell types.  As 
shown in Figure 18A, intracellular 5’ppp-ssRNA administration induces significant IL-6 
and TNF-  production as early as 6 hours following transfection in primary microglia.  
Similarly, murine astrocytes also produce these inflammatory cytokines in response to 
5’ppp-ssRNA (Figure 18B).  Taken together, these data indicate that specific activation 
of RIG-I elicits glial inflammatory responses. 
 To confirm the functional status of RIG-I in murine glia and to begin to determine 
the relative importance of this sensor in glial responses to RNA viruses, we have assessed 
the effect of RIG-I knockdown on inflammatory cytokine production by VSV-infected 
microglia and astrocytes using silencing RNA techniques.  Similar to our previous 
findings in human astrocytes (Furr et al., 2010), virally-induced production of TNF-  
was specifically and markedly inhibited in murine astrocytes transfected with siRNA 
targeting RIG-I as compared to control cells that were transfected with scrambled non-
specific siRNA (Control) (Figure 19A).  Importantly, RIG-I knockdown abolished 
inflammatory mediator release by VSV-challenged microglia (Figure 19B).  The ability 
to inhibit cytokine production was specific for this RNA sensor, as transfection with 
siRNA directed against the DNA sensor, DAI, failed to significantly affect VSV-induced 
TNF-  release by either microglia or astrocytes (Figure 19).  Furthermore, when cells 
were transfected with siRNA targeting both sensors, there was no additional effect on 
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cytokine production versus RIG-I knockdown alone (Figure 19).  These results indicate 
that RIG-I activation provides a full and sufficient signal for glial responses to this 
neurotropic RNA virus. 
 To determine if RIG-I also plays a role in glial sensing of viral DNA and to begin 
to determine the relative importance of this innate immune sensor in microglial and 
astrocyte responses to DNA viral challenge, we have assessed the effect of RIG-I 
knockdown on glial production of TNF-  following infection with the DNA virus HSV-
1.  We have previously shown that DAI plays an important role in glial responses to this 
virus and this finding was confirmed here as transfection with siRNA directed against 
DAI attenuated cytokine production by HSV-1 challenged microglia or astrocytes by 
approximately 67% and 30% at the highest MOI, respectively (Figure 20).  Surprisingly, 
RIG-I knockdown also inhibited such responses in both cell types and to the same degree 
as DAI knockdown (Figure 20).  When transfected with siRNAs targeting both DAI and 
RIG-I, HSV-1-induced TNF-  production by microglia was reduced by approximately 
80% to levels that were not significantly different from those produced by uninfected 
cells (Figure 20A), while cytokine production by astrocytes was also reduced albeit to a 
lesser extent (60%).  Taken together, these data indicate that RIG-I may play a significant 
role in the perception of DNA viruses by glia, and that this RNA sensor may act in a 
cooperative manner with DAI to induce inflammatory immune responses by these cells.
 To begin to determine the mechanisms underlying the involvement of the RNA 
sensor RIG-I in glial responses to this DNA virus we have investigated the involvement 
of RNA polymerase III in these responses.  As shown in Figure 20, pre-treatment of cells 
with the selective RNA polymerase III inhibitor Tagetin (10 U/ml) (Epicentre 
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Biotechnologies) significantly reduced HSV-1-mediated TNF-  production by microglia 
and astrocytes to the same extent as RIG-I knockdown (approximately 62% and 30%, 
respectively).  Furthermore, when the inhibitor was utilized in concert with DAI 
knockdown, microglial responses were reduced by approximately 85% and those of 
astrocytes by 50%, to levels equivalent to those observed in cells transfected with siRNA 
against both DAI and RIG-I (Figure 20).  It is important to note that RNA polymerase III 
inhibitor treatment failed to significantly alter glial cytokine responses following VSV 
infection (Figure 19).  As such, these findings suggest that RIG-I could play a 
cooperative role with DAI in the detection of DNA viruses following the generation of 
RNA ligands from cytosolic viral DNA by RNA polymerase III. 
5.3 Conclusions 
 As aforementioned, viral infections in the CNS trigger glial activation and the 
subsequent release of proinflammatory cytokines and chemotactic molecules (Aravalli et 
al., 2005; Lokensgard et al., 2001; Cheeran et al., 2005; Marle et al., 2007).  We have 
documented the ability of primary cultured microglia and astrocytes to respond to 
disparate RNA and DNA viruses, including VSV, Sendai virus, murine 
gammaherpesvirus (MHV)-68, and HSV-1, by producing inflammatory mediators such 
as IL-6, TNF- , and IL-1  (Chauhan et al., 2010; Rasley et al., 2004).  These 
characteristics suggest that the innate immune responses of resident CNS cells play a 
pivotal role in disease progression. However, the mechanisms by which these cells 
recognize viral pathogens have not been fully defined.  It is becoming increasingly 
apparent that glia possess intracellular sensors that can detect compromise of the 
cytosolic compartment.  While most RNA viruses replicate in the cytoplasm and 
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therefore allow detection of viral replicative motifs by RLRs present in the host cells, 
many DNA viruses are known to replicate in the nucleus.  In addition, DAI detects a 
structure common to both self and non-self DNA.  This suggests that the discrimination 
between these types of DNA is based on its subcellular localization, and may likely be a 
function of the amount and the length of the DNA present in the cytosol rather than a 
specific chemical feature of the ligand (as reviewed in Keating et al., 2011).   However, a 
recent study has shown that HSV-1 DNA, mislocated from the viral capsid, is readily 
detectable in the cytoplasm of infected RAW264.7 macrophages, bone marrow-derived 
macrophages (BMDMs), and THP-1 cells (Unterholzner et al., 2010), suggesting that 
both viral RNA and DNA can be detected by receptors present in the cytosol. 
 We have recently demonstrated that murine and human glial cells constitutively 
express robust levels of RIG-I and MDA5 and that the expression of RIG-I in primary 
glial cells is induced following infection with the model RNA virus, VSV (Furr et al., 
2008).  Importantly, the present study shows that intracellular administration of in vitro 
generated 5’ppp-ssRNA, a reported ligand for RIG-I, induces RIG-I expression in 
primary murine astrocytes, which is consistent with our previous findings in human 
astrocytes.  Furthermore, we have also provided the first evidence that RIG-I expression 
in murine microglia is inducible following transfection with 5’ppp-ssRNA. As such, the 
present demonstration of robust levels of RIG-I in resting microglia and astrocytes is 
consistent with the ability of these cells to mount rapid inflammatory immune responses 
following viral challenge.  In addition, the inducible nature of such expression by intact 
viral particles and a specific ligand for RIG-I suggests that these cells may become 
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sensitized to the presence of intracellular viral moieties produced during viral replication 
in a feed-forward manner. 
 Perhaps more importantly, in the present study we provide the first demonstration 
that this RLR plays an important role in the inflammatory immune responses of murine 
astrocytes and microglia to viral infection.  Similar to our findings in human astrocytes, 
we have demonstrated that 5’ppp-ssRNA delivered intracellularly into primary murine 
astrocytes elicits significant inflammatory cytokine production.  Interestingly, primary 
microglia also produce significant amounts of IL-6 and TNF-  following transfection 
with this specific ligand.  Finally, we have confirmed a role for this intracellular viral 
sensor in the immune responses of glial astrocytes to a model neurotropic rhabdovirus by 
demonstrating that RIG-I knockdown specifically and significantly inhibits VSV-induced 
cytokine production. 
 Recent studies have demonstrated that RIG-I may be important in the production 
of type I IFNs by cells in response to DNA viral challenge in a DNA-dependent RNA 
polymerase III manner (Ablasser et al., 2009; Chui et al., 2009).  In this described 
pathway, AT-rich double-stranded DNA serves as a template for RNA polymerase III 
and is transcribed into RNA containing a 5'-triphosphate, the ligand for RIG-I.  
Subsequent activation of RIG-I by this ligand has been shown to induce type I IFN 
production and to activate NF- B, and studies employing RNA polymerase III 
knockdown or pharmacological inhibitors of this enzyme have shown that this pathway is 
important in cell responses to the gammaherpesvirus Epstein-Barr virus (Ablasser et al., 
2009; Chui et al., 2009).  Indirect evidence for an ability of RIG-I to perceive DNA 
pathogens comes from the finding that the DNA virus HSV-1, as well as synthetic DNA 
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ligand reported to activate the cytosolic viral DNA sensor DAI, are able to elicit 
upregulation of RIG-I expression in astrocytes and microglia. More direct evidence for a 
role for RIG-I in the detection of DNA comes from our studies which indicate that 
inhibition of RNA polymerase III or knockdown of RIG-I can markedly inhibit the 
inflammatory responses of murine glial cells to HSV-1 infection.  Collectively, these 
studies provide the first evidence that the transcription of cytosolic viral DNA by RNA 
polymerase III and subsequent RNA recognition by RIG-I may provide an additional 
mechanism for the perception of DNA viruses by CNS cells. 
 Interestingly, our findings suggest a dual role for RIG-I in the recognition of both 
RNA and DNA viruses in glial cells.  The observation that both RIG-I and DAI are 
necessary to mount a maximal immune response to DNA pathogens is in line with our 
demonstration that DAI knockdown attenuates but does not abolish glial responses to 
HSV-1 (Figure 7).  While the ability of a specific inhibitor of RNA polymerase III to 
attenuate inflammatory cytokine production by infected glial cells provides strong 
support that RIG-I detects RNA moieties transcribed from cytosolic viral DNA, we 
cannot discount the possibility that other interactions between the DAI and RIG-I 
signaling pathways exist in microglia or astrocytes.  For example, the adaptor molecule 
STING has been shown to play a role in both RIG-I and DAI signaling pathways 
(Ishikawa and Barber, 2008).  As such, the possibility exists that the RIG-I and DAI 
signaling pathways converge at this component to facilitate cellular activation.  
Alternatively, it is also conceivable that RIG-I and DAI could interact either directly or 
via STING to promote inflammatory responses.  In support of this possibility, previous 
immunoprecipitation studies have indicated that STING associates with RIG-I complexes 
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in close proximity to endoplasmic reticulum associated mitochondria (Ishikawa et al., 
2009; Dixit et al., 2010).  However, it remains to be determined whether DAI associates 
with RIG-I, STING, or other components associated with RIG-I signaling in glial cells. 
 In the present study, we show that glial inflammatory responses to the DNA virus 
HSV-1 are dependent on the expression of DAI and RIG-I and the activity of polymerase 
III, while glial responses to the RNA virus VSV required the expression of RIG-I but 
were DAI and polymerase III independent.  Collectively, these studies provide the first 
evidence that both RIG-I and DAI play a critical role in the recognition of viral 
pathogens by resident CNS cells and suggest that these novel intracellular pattern 
recognition receptors may underlie the damaging inflammation and neuronal cell death 
associated with acute neurotropic viral infections 
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5.4 Figures 
 
 
FIGURE 16:  5’ppp-ssRNA induces RIG-I expression in primary murine glial cells. Cells 
(2 X 10
6
) were untreated (0) or exposed to 5’ triphosphate ssRNA (ppp-ssRNA: 4 or 8 
ug/ml) in the presence of FuGENE transfection reagent.  At 6 hours following 
transfection, RIG-I protein expression was assessed in whole cell lysates by immunoblot 
analysis.  For comparison purposes, RIG-I protein expression in a similar number of 
resting HeLa cells is shown (+).  Representative results are shown for one of three 
separate experiments.   
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FIGURE 17:  Dissimilar motifs induce RIG-I expression in primary murine glial cells.   
Panel A: Microglia (2 X 106) were untreated (0) or infected with HSV-1 (MOI of 0.1, 1, and 10).  
At 12 hours p.i., expression of RIG-I was determined in whole cell protein isolates by 
immunoblot analysis. Panel B: Astrocytes (2 X 106) were untreated (0) or infected with HSV-1 
(MOI of 0.1, 1, and 10).  At 12 and 24 hours p.i., expression of RIG-I was determined in whole 
cell protein isolates by immunoblot analysis. Panel C: Cells (2 X 10
6
) were untreated (0) or 
exposed to B-DNA (3 or 6 8 ug/ml).  At 6 hours following transfection, RIG-I protein 
expression was determined in whole cell lysates by immunoblot analyses.  Representative 
results are shown of one of three separate experiments. 
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FIGURE 18:  Single stranded RNA induces inflammatory mediator production by 
primary murine glial cells.  Microglia (Panel A) and astrocytes (Panel B) were untreated 
(0) or treated with transfection reagent alone (FG), or exposed to 5’ triphosphate ssRNA 
(5’ppp-ssRNA: 4 or 8 ug/ml) in the presence of the transfection reagent. At 6 hrs 
following transfection, supernatants were collected and IL-6 and TNF-  levels were 
measured by ELISA analyses.  Data is expressed as mean +/- SEM (n = 3).  An asterisk 
indicates a statistically significant difference from unstimulated cells (p < 0.05). 
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FIGURE 19:  RIG-I knockdown abolishes VSV-induced inflammatory cytokine 
production by primary glia.  Astrocytes (Panel A) and microglia (Panel B) were untreated 
(0), or transfected with siRNA targeting RIG-I, DAI, or scrambled siRNA (Control).  At 
72 hours following transfection, cells were infected with VSV (MOI of 0.1, 1, and 10) 
and the levels of TNF-  in the culture supernatants were assayed by specific capture 
ELISA at 12 hours p.i.  Data is expressed as mean +/- SEM (n = 3).  An asterisk indicates 
a statistically significant difference from unstimulated cells; a pound symbol indicates a 
statistically significant difference between cells transfected with siRNA directed against 
RIG-I or DAI versus scrambled siRNA (p < 0.05). 
85 
 
 
FIGURE 20:  Both RIG-1 and DAI are involved in cellular responses to the DNA virus, 
HSV-1. Microglia (Panel A) and astrocytes (Panel B) were untreated (0), or transfected 
with siRNA targeting RIG-I, DAI, both RIG-I and DAI (Both) or scrambled siRNA 
(Control).  At 72 hours following transfection, cells were infected with HSV-1 (MOI of 
0.1, 1, and 10), and the levels of TNF-  in the culture supernatants were assayed by 
specific capture ELISA at 24 hours p.i.  Additionally, cells were pretreated with RNA 
polymerase III inhibitor alone (PI) or in following DAI knockdown (DAI + PI). 8 hours 
following inhibitor treatment, cells were infected with HSV-1 at an MOI of 10, and the 
levels of TNF-  in the culture supernatants were assayed by specific capture ELISA at 24 
hours p.i.  Data is expressed as mean +/- SEM (n = 3).  An asterisk indicates a 
statistically significant difference between cells transfected with siRNA directed against 
RIG-I or DAI versus scrambled siRNA, in cells infected with the same MOI of HSV-1 (p 
< 0.05). A pound symbol indicates a statistically significant difference between PI and 
DAI + PI. (p < 0.05).  
CHAPTER SIX:  SUMMARY AND CONCLUSIONS 
 
 
6.1  DAI plays an important role in inflammatory and neurotoxic responses of  
glial cells to DNA viral pathogens 
 
In the CNS, we have shown that microglia and astrocytes constitutively express 
DAI and its effector molecules RIP3 and STING, and show that such expression is 
upregulated following DNA virus challenge (Furr et al., 2011).  In vivo HSV-1 infection 
elicited an upregulation in microglial DAI expression by up to 23.8 fold over that seen in 
resting cells, and despite strong constitutive expression, HSV-1 exposure was also able to 
further increase DAI expression in astrocytes with a maximal increase of 2.2 fold over 
that seen in unstimulated cells.  Interestingly, the ability of viral challenge to augment 
DAI expression by primary glial cells was not limited to this neurotropic 
alphaherpesvirus, as the lymphotropic gammaherpesvirus, MHV-68, was also capable of 
eliciting robust increases in microglial DAI expression and caused modest increases in 
the expression of this molecule in astrocytes.   
Importantly, we showed that transfection with the DAI specific ligand B-DNA 
elicits inflammatory cytokine production by isolated glial cells, with induced production 
of the inflammatory cytokines TNF-  and IL-6 as rapidly as 6 hours post-transfection at 
levels that matched or exceeded those elicited following a 24-hour HSV-1 challenge 
(Furr et al., 2011).  To confirm the functional status of DAI in glial cells and to begin to 
determine the relative importance of this innate immune sensor 
87 
 
in their responses to neurotropic DNA viruses, we also assessed the effect of DAI 
knockdown on inflammatory cytokine production by HSV-1 challenged microglia and 
astrocytes (Furr et al., 2011).  We found that siRNA directed against DAI significantly 
attenuated HSV-1 induced TNF-α and IL-6 production by murine microglia. Such an 
approach also markedly reduced IL-6 production by HSV-1 infected astrocytes but was 
not as effective in reducing TNF-α production by these cells, where a statistically 
significant reduction was only observed at the highest viral MOI used (Furr et al., 2011).  
Lastly, we demonstrated that HSV-1 challenged microglia and astrocytes release 
neurotoxic mediators and showed that such production is significantly attenuated 
following DAI knockdown (Furr et al., 2011).  As such, we propose the model shown 
below in Figure 21.   
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FIGURE 21.  Proposed model by which glia recognize neurotropic DNA viruses such as 
HSV-1 and elicit inflammatory CNS damage. 
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We suggest that neurotropic double-stranded DNA viruses such as HSV-1 infect 
microglia and astrocytes and replicate within them, generating genomic DNA within the 
cytoplasm of each cell type.  These viral DNA motifs are then recognized by DAI leading 
to the activation of downstream effector molecules including IPS-1, STING, and RIP3.  
Their activation ultimately liberates the RelA subunit of NF- B allowing it to translocate 
to the nucleus and to initiate the de novo production of soluble inflammatory mediators.  
In addition, it is possible that RNA polymerase III in the cytosol could transcribe the viral 
DNA templates into double stranded RNA containing 5'-triphosphate which, in turn, 
could be recognized by RIG-I and similarly activate NF- B via the adaptor molecules 
IPS-1 and STING.  Once production is initiated, cytokines such as TNF-  and IL-6 
would be anticipated to promote inflammation and to increase blood-brain barrier 
permeability, facilitating leukocyte recruitment into the CNS.  In addition, other soluble 
inflammatory mediators such as NO can also initiate neuronal cell loss, either directly or 
via activation of resident/infiltrating myeloid cells.  As such, the functional expression of 
DAI by glial cells may represent an important innate immune mechanism underlying the 
rapid and potentially lethal inflammation associated with neurotropic DNA virus 
infection (Figure 21). 
6.2  RIG-I plays an important role in the initiation of inflammatory and  
neurotoxic responses to RNA pathogens in human astrocytes 
 
Evidence for the functional nature of RIG-I expression in these cells comes from 
our observation that this molecule associates with IPS-1 following VSV infection and 
from the finding that the specific RIG-I ligand, 5’ppp-ssRNA, elicits human astrocyte 
immune responses (Furr et al., 2010).  This work also demonstrated that RIG-I mediates 
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TNF-  production by human astrocytes (Furr et al., 2010).  Importantly, we have shown 
that RIG-I knockdown significantly reduces inflammatory cytokine production by VSV-
infected astrocytes and inhibits the production of soluble neurotoxic mediators by these 
cells.  These findings directly implicate RIG-I in the initiation of glial inflammatory 
immune responses and suggest a potential mechanism underlying the neuronal cell death 
associated with acute viral CNS infections (Furr et al., 2010).  Based upon the present 
study, we propose a model shown below in Figure 22.  
 
FIGURE 22. Proposed model by which human astrocytes recognize neurotropic RNA 
viruses and elicit inflammatory CNS damage. 
 
We suggest that non-segmented, negative-sense RNA viruses infect astrocytes 
and replicate within them, generating uncapped genomic RNAs with phosphorylated 5'-
ends.  These motifs are recognized by RIG-I and such recognition leads to an association 
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of the CARD domains of this molecule with those of the downstream effector molecule, 
IPS-1.  Activated IPS-1 ultimately liberates the RelA subunit of NF- B allowing it to 
translocate to the nucleus and to initiate the de novo production of soluble inflammatory 
mediators.  Mediators such as TNF-  and IL-6 are well recognized to initiate 
inflammation and to increase blood-brain barrier permeability, facilitating leukocyte 
recruitment into the CNS.  In addition, such soluble mediators can also initiate neuronal 
cell loss, either directly or via activation of resident/infiltrating myeloid cells.  The 
expression of this RLR by human astrocytes may therefore represent an important innate 
immune mechanism underlying the rapid and potentially lethal CNS inflammation 
associated with neurotropic RNA virus infections. 
6.3  RIG-I is essential for the recognition of both RNA and DNA viral pathogens  
in the CNS  
 
 We have definitively shown important roles for both RIG-I and DAI in the 
recognition of RNA and DNA viral pathogens, respectively.   Interestingly, the 
observation that both RIG-I and DAI are necessary to mount a maximal immune response 
to DNA pathogens is in line with our demonstration that DAI knockdown attenuates but 
does not abolish glial responses to HSV-1 (Furr et al., 2011).  While the demonstrated 
ability of a specific inhibitor of RNA polymerase III to attenuate inflammatory cytokine 
production by infected glial cells provides strong support that RIG-I detects RNA 
moieties transcribed from cytosolic viral DNA, we cannot discount the possibility that 
other interactions between the DAI and RIG-I signaling pathways exist in microglia or 
astrocytes.  For example, the adaptor molecule STING has been shown to play a role in 
both RIG-I and DAI signaling pathways (Ishikawa and Barber, 2008).  As such, the 
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possibility exists that the RIG-I and DAI signaling pathways converge at this component 
to facilitate cellular activation.  Alternatively, it is also conceivable that RIG-I and DAI 
could interact either directly or via STING to promote inflammatory responses.  In 
support of this possibility, previous immunoprecipitation studies have indicated that 
STING associates with RIG-I complexes in close proximity to endoplasmic reticulum 
associated mitochondria (Ishikawa et al., 2009; Dixit et al., 2010).  However, it remains 
to be determined whether DAI associates with RIG-I, STING, or other components 
associated with RIG-I signaling in glial cells. Collectively, these studies indicate that the 
transcription of cytosolic viral DNA by RNA polymerase III and subsequent RNA 
recognition by RIG-I may provide an additional mechanism for the perception of DNA 
viruses by CNS cells.   
 Taken as a whole, these studies provide evidence for the functional expression of 
the pathways shown below in solid lines following viral infection of glial cells (Figure 
23).   
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FIGURE 23.  Proposed pathways involved in glial inflammatory responses to neurotropic 
viruses. 
 
In this model, RNA viruses infect glial cells and generate disparate RNA motifs, 
which can be recognized by the RLRs, MDA5 and RIG-I.  Following engagement with 
RIG-I, IPS-1 association results in translocation of NF-kB to the nucleus and the 
subsequent production of inflammatory cytokines.  Similarly, DNA virus infection of 
glial cells results in detection of dsDNA moieties generated in the cytoplasm by DAI.  
DAI activation upregulates the expression of downstream adaptors, including STING and 
RIP3, and initiates the subsequent production of inflammatory cytokines.  In addition, 
dsDNA from DNA virus infection can be transcribed into RNA that can be recognized by 
RIG-I through an RNA polymerase III-dependent pathway.  However, it is highly likely 
that glial responses represent the sum of the inputs from multiple disparate cytosolic viral 
94 
 
sensors.  In summary, the current study provides strong evidence that these cytosolic 
pattern recognition receptors serve an important role in the generation of potentially 
damaging neuroinflammation by glial cells in response to viral pathogens. 
6.4  Potential for future studies 
The importance of innate immunity in response to viral infection of the CNS is 
clear.  Microglia and astrocytes express a diverse array of cell surface, endosomal and 
cytosolic molecules that can serve as sensors for RNA and DNA viruses, either 
constitutively or following activation.   The diversity of ligands recognized, the exquisite 
control of the signaling pathways, and the complexity of the interactions between the 
innate and adaptive arms of the immune response are also apparent.  However, it is also 
clear that we still do not fully understand the precise nature and structure of the ligands 
for many of these PRRs or their mode of generation during infection.  Furthermore, the 
available data suggest that models that ascribe discrete PRRs to each particular pathogen 
are overly simplistic.  Rather, it appears that TLRs, RLRs, NLRs, and DAI function as 
PRRs and/or adaptor molecules that act in a cooperative/synergistic manner to promote 
glial responses to viral pathogens.   
Much work obviously remains to be done, as it is almost certain that additional 
PRRs await discovery in glial cells and the nature of the interactions between these viral 
sensors and their signaling pathways have not been determined (see Figure 23; dashed 
lines).  In addition, it is presently unclear whether and to what degree viral CNS 
pathogens evade detection or manipulate the glial immune responses to their advantage.  
Answering these questions will lead to greater understanding of the fundamental 
mechanisms underlying resident CNS cell activation by neurotropic viruses and will 
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contribute significantly to our understanding of the events that underlie the development 
of either protective host responses or life threatening neuroinflammation. 
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